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Abstract 
Galactooligosaccharides are produced by the transglycosylation activity of β-
galactosidases (β-gal, EC 3.2.1.23) when utilising lactose as a substrate. They have 
emerged as important constituents used in the food and pharmaceutical industries 
owing to their prebiotic properties. Although transglycosylation was discovered in 
1951 (Wallenfels 1951), and a number of β-gals have had their transglycosylation 
activity characterised, the activities of these enzymes are not optimal for industrial 
use. Their tendency to favour the hydrolytic reaction over the transglycosylation 
reaction, coupled with the production of shorter chain oligosaccharides has driven 
scientists to investigate altering protein structure both to increase chain lengths and 
the amount of oligosaccharide produced at lower substrate concentrations. 
 
In an attempt to alter the amount of oligosaccharide produced by a metagenomically 
derived β-gal belonging to the glycosyl hydrolase 2 family, random and site-directed 
mutagenesis were used. A randomly mutagenised library was screened on SOB 
agar plates containing 5% (w/v) lactose which should select for clones that 
synthesise oligosaccharides at relatively low concentrations. No such activity was 
detected. Site-directed mutagenesis was also utilised to alter protein structure. It was 
confirmed that the β-gal utilised in this study belonged to the glycosyl hydrolase 2 
family through mutation of the predicted catalytic acid/base glutamic acid to a non-
catalytic residue, thus removing activity. Another mutation was utilised to investigate 
if it was possible to increase the degree of polymerisation of oligosaccharides 
produced by the β-gal. This mutation was successful in increasing the degree of 
polymerisation.  
 
Biochemical characterisation of the β-gal revealed that it exhibited optimal activity at 
pH 8.0, with a temperature optimum of 30°C. The β-gal exhibited a Km and Vmax of 
54.23 mM and 2.26 µmol/minute-1/mg protein-1 respectively, similar to kinetic 
parameters that have been determined for a number of previously characterised 
enzymes.  
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Opsomming 
Galaktooligosakkariede word geproduseer deur die transglikosileering aktiwiteit van 
β-galaktosidase (β-gal, EG 3.2.1.23) wanneer hulle laktose as 'n substraat gebruik. 
Hierdie oligosakkariede het na vore gekom as 'n belangrike bestandeel vir gebruik in 
die voedsel en farmaseutiese bedryf as gevolg van hulle prebiotiese eienskappe. 
Alhoewel transglycosylation al in 1951 ontdek is (Wallenfels 1951) en 'n aantal β-
gals se transglycosylation aktiwiteit gekenmerk is, is hierdie ensieme nie ideaal vir 
industriële toepassings nie. Die geneigdheid om die hidrolitiese reaksie oor die 
transglycosylation reaksie bevoordeel, tesame met die produksie van korter 
oligosakkariede het wetenskaplikes ondersoek genoop om die proteïenstruktuur te 
verander om ketting-lengte en die kwantiteit van oligosakkaried geproduseer teen 
laer substraat konsentrasies te verhoog. 
 
In 'n poging om die opbrengs van die oligosakkaried wat deur 'n metagenomiese β-
gal wat aan die glycosyl hidrolase 2 familie behoort te verander, is lukraak en terrein 
gerigte-mutagenese gebruik. Die mutagenese biblioteek is op SOB agarplate met 
5% (w/v) lactose gekeur, om klone wat die fenotipe wat verband hou met die 
produksie oligosakkaried teen relatiewe lae konsentrasies te selekteer. Geen 
aktiwiteit is opgemerk nie. Terrein gerigte-mutagenese is ook gebruik om die 
proteïenstruktuur te verander. Deur ‘n bioinformatiese voorspelling, is dit bevestig 
dat die β-gal wat in hiedie studie gebruik word tot die glycosyl hidrolase 2 familie 
behoort. Dit is gedoen deur mutasie van die voorspelde katalitiese suur/basis 
glutamiensuur na 'n nie-katalitiese oorskot, dus die verwydering van aktiwiteit. Nog ‘n 
mutasie is gebruik om te ondersoek of dit moontlik was om die ketting-lengte van die 
oligosakkaried wat deur die β-gal geproduseer is te verhoog. Die mutasie was 
suksesvol in die verhoging van die oligosakkaried wat geproduseer was. 
 
Biochemiese karakterisering van die β-gal het getoon dat hierdie β-gal optimale 
aktiwiteit het by pH 8.0, met 'n optimum temperatuur van 30°C. Die β-gal het 'n Km 
en Vmax van 54.23 mM en 2.26 µmol/minute
-1/mg proteïen-1 onderskeidelik, 
soortgelyk aan kinetiese parameters wat bepaal word vir ensieme wat voorheen 
gekenmerk is.  
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1. General Introduction 
 
Oligosaccharides are food ingredients that can be classed as prebiotics as they 
selectively stimulate the proliferation of Bifidiobacteria and other probiotic 
microorganisms in the gastrointestinal tract, that infer numerous health benefits to 
the host (Roberfroid and Slavin 2000; Macfarlane et al. 2008; Roberfroid et al. 2010). 
Their commercial importance has been steadily increasing over the last decade. 
Market analysts Frost & Sullivan estimate that the demand for pre- and probiotic 
products in the European market will reach €766.9 million in 2015, up from €295.5 
million in 2008 – a compound annual growth of 14% (Feick 2009).  
 
One class of oligosaccharides, galactooligosaccharides (GOS) can be produced 
from the transglycosylation activity of β-galactosidase (β-gal) utilising the 
disaccharide lactose as a substrate, and are considered to be prebiotic 
oligosaccharides (Gosling et al. 2010). Novel biological treatments to convert lactose 
into GOS have been receiving increased attention, due both to the health benefits 
they can confer when ingested (Yang and Silva 1995; González Siso 1996; Prazeres 
et al. 2012) and an increase in consumer health awareness (Mattila-Sandholm et al. 
2002; Grunert and Wills 2007). These benefits include increased mineral uptake 
(Chonan et al. 1995; Scholz-Ahrens et al. 1998, 2001; Mussatto and Mancilha 2007), 
modifying the intestinal microflora (Gibson et al. 2004; Roberfroid et al. 2010), and 
reducing the risk of intestinal cancer (Guarner and Malagelada 2003; Bruno-Barcena 
and Azcarate-Peril 2015). The enzymatic treatment of lactose with β-gal is the main 
method utilised by industry to synthesise GOS, but the use of this enzyme has 
drawbacks as the oligosaccharide products can also be hydrolysed by it. This has 
led scientists to isolate and characterise new β-gals that favour transglycosylation 
over hydrolysis, as well as to utilise protein engineering to modify existing enzymes 
so that the oligosaccharides they produce have a longer degree of polymerisation.  
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1.1. Oligosaccharides 
Carbohydrates can be classified according to their molecular weight or degree of 
polymerisation (DP), into monosaccharides, oligosaccharides or polysaccharides 
(Crittenden and Playne 1996; Mussatto and Mancilha 2007). Oligosaccharides are 
defined as carbohydrates consisting of between three and ten monosaccharide units 
linked together by a glycosidic bond (Crittenden and Playne 1996). They can be 
further subdivided into hetero- and homo-oligosaccharides, which can be made up of 
anionic (hexoses) or neutral (pentoses and hexoses) sugars (Badel et al. 2011). 
Oligosaccharides can be branched or linear, with each monosaccharide being 
connected by either an α or β glycosidic linkage (Sears and Wong 2001). This 
means that there are a very large number of potential oligosaccharide structures that 
might exist due to the diversity of sugars that can be incorporated, bonds that can 
exist between them and branch points that can be introduced.  
 
Oligosaccharides are water soluble and can taste sweet, although less so than 
sucrose. The sweetness depends on the DP of the oligosaccharide as well as its 
structure (Crittenden and Playne 1996; Voragen 1998). Owing to these 
characteristics, oligosaccharides are utilised as bulking agents and thickeners in the 
food industry (Crittenden and Playne 1996; Rivero-Urgell and Santamaria-Orleans 
2001). Due to their selective degradation and fermentation, they are considered low 
cariogenic sugar substitutes, and can be used to alter the freezing temperature of 
foods (Lamsal 2012).  
 
Oligosaccharides are synthesised either through chemical or enzymatic reactions 
(Perugino et al. 2005). Because of the immense structural complexity that they can 
possess chemical synthesis is highly complex. The presence of a number of -OH 
groups with similar reactivity can result in highly branched structures being formed 
(Perugino et al. 2004). Selective synthesis of oligosaccharides can be achieved 
through the use of protection groups that bind to -OH radical, but the difficulty of this 
process and relatively low yields of end product have resulted in enzymatic synthesis 
being favoured (Sears and Wong 2001). This has received the most attention for 
applications in industry as enzymes possess very tight regio- and stereoselectivity. 
This means that the final products can be manufactured in a reproducible manner on 
a large scale. 
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1.1.1. Galactooligosaccharides 
GOS structures can differ in a number of ways; namely saccharide composition, DP 
and type of glycosidic linkage (Gosling et al. 2010). These structural differences can 
alter the properties of GOS and, thus, how they are utilised in the food industry 
(Mahoney 1998; Gosling et al. 2010; Sangwan et al. 2011). There is evidence that 
suggests that microorganisms propagate differently when fermenting different 
oligosaccharide structures; this needs to be taken into account when formulating 
prebiotic products for the market to ensure propagation of probiotic microflora in the 
gastrointestinal tract (GIT) of hosts (Gosling et al. 2010; Marín-Manzano et al. 2013). 
 
The general composition of GOS consist of a terminal glucose unit linked to one or 
more galactose units (Gosling et al. 2010; Gänzle 2012; Yu and O’Sullivan 2014), 
however branched structures as well as GOS lacking a terminal glucose moiety (Gal-
Gal) also exist (Table 1) (Mahoney 1998). GOS are highly stable compounds, 
capable both of being stored for long periods of time and being resistant to high 
temperatures. These properties allow them to be utilised in foods that undergo 
pasteurization (Klewicki 2007). 
 
Table 1: Oligosaccharide structures commonly found in GOS mixtures (Mahoney 1998). 
Degree of Polymerisation Linkage 
Disaccharides β-Gal (1→6)-Glc 
β-Gal (1→6)-Gal 
β-Gal (1→2)-Glc 
β-Gal (1→3)-Glc 
β-Gal (1→3)-Gal 
Trisaccharides β-Gal (1→6)-β-Gal (1→6)-Glc 
β-Gal (1→6)-β-Gal (1→6)-Gal 
β-Gal (1→6)-β-Gal (1→4)-Glc 
β-Gal (1→3)-β-Gal (1→4)-Glc 
β-Gal (1→4)-β-Gal (1→4)-Glc 
Tetrasaccharides β-Gal (1→6)-β-Gal (1→6)-β-Gal (1→4)-Glc 
β-Gal (1→6)-β-Gal (1→3)-β-Gal (1→4)-Glc 
β-Gal (1→3)-β-Gal- (1→6)-β-Gal (1→4)-Glc 
Pentasaccharides β-Gal (1→6)-β-Gal (1→6)-β-Gal (1→6)-β-Gal(1→4)-Glc 
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1.1.2. Industrial production of galactooligosaccharides 
The commercial production of GOS utilises high concentrations of lactose as a 
substrate, in the form of either whey permeate or refined lactose (Lamsal 2012). 
Whey permeate is an attractive substrate for use, as it is readily available as a waste 
product from the cheese manufacturing process. The GOS manufacturing process 
usually utilises batch mode fermentation in conjunction with β-gal enzyme 
immobilised on a matrix; although hollow fibre membrane reactors, fixed bed 
reactors and continuous stirred tank reactors with “free enzyme” have all been used 
as methods for production (Boon et al. 2000b; Gänzle et al. 2008; Gänzle 2012). 
Although the free enzyme approach is the simplest to implement, enzyme isolation 
and purification in conjunction with the enzyme preparations not being reusable 
result in high input costs (Gosling et al. 2010). The batch mode is the manufacturing 
method of choice due to its ease of implementation, its minimisation of 
contamination, and relatively low cost as the enzyme can be reused (Boon et al. 
2000b; Gänzle 2012; Lamsal 2012). GOS manufacturers also have to address 
problems with the β-gals that they use for GOS synthesis – the enzymes do not 
produce oligosaccharides at high enough rates. This has led to research being 
conducted to identify and characterise novel β-gals with high transglycosylation 
activity. At the end of a production run, all GOS mixtures go through the same 
decolourisation and demineralisation treatments before being filtered and 
concentrated in an evaporator (Sako et al. 1999; Otieno 2010). Commercial GOS 
products are available in either syrup or powder form, and contain a mixture of DP as 
well as residual lactose, glucose and galactose (Torres et al. 2010). Table 2 shows 
some producers of GOS, as well as the origin of the enzymes that they utilise in their 
GOS production.  
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Table 2: Manufacturers of commercial GOS (Tzortzis and Vulevic 2009; Torres et al. 2010; Sangwan 
et al. 2011; Bruno-Barcena and Azcarate-Peril 2015). 
Manufacturer Product Enzyme Origin 
Corn Products Intl. USA Purimune - powder Bacillus circulans 
Clasado Ltd. United Kingdom Bimuno – syrup and powder Bifidiobacterium bifidum 
Fayrefield Food. United Kingdom Promotiva – syrup Bacillus circulans 
Friesland Foods Domo. 
Netherlands 
Vivinal GOS – syrup and powder Bacillus circulans 
Nissin Sugar Manufacturing Co. 
Japan 
CUP-oligo – syrup and powder Cryptococcus laurentii 
Yakult Honsha. Japan Oligomat 55NP – syrup and powder Aspergillus oryzae 
Streptococcus thermophilus 
Sporobolomyces singularis 
 
1.2. Functional foods 
The term ‘functional foods’ was first utilised in Japan in the 1980’s. They can be 
defined as food or food ingredients that, when consumed, impart physiological or 
health benefits to the organism ingesting them over and above the nutritional value 
of the food (Gibson et al. 2004; Sangwan et al. 2011). As the definition of a 
functional food is broad, a large number of different compounds fall into this 
category; prebiotics, probiotics, vitamins, minerals and antioxidants have all been 
classified as components of functional foods (Sangwan et al. 2011). Currently 
prebiotics and probiotics have received the greatest attention and are the most 
widely utilised and studied functional foods in the world (Figueroa-González et al. 
2011; Sangwan et al. 2011).  
 
Probiotics are defined as “non-pathogenic microorganisms which confer a health 
benefit on the host and are able to prevent or improve some diseases when 
administered in adequate amounts” (Gibson and Roberfroid 1995; Gibson et al. 
2004; Fric 2007). It is accepted that they benefit human health through competing 
with pathogenic microbes that can cause disease, induce immune system responses 
and produce substances that influence the wellbeing of their hosts (Saier and 
Mansour 2005). Prebiotics on the other hand are defined as being non-digestible 
oligosaccharides (NDO’s) that are selectively fermented by the beneficial bacteria 
that are already present in the GIT and which confer a health benefit to the host (Fric 
2007; Otieno 2010; Figueroa-González et al. 2011). Among the microorganisms 
populating the GIT, Bifidiobacterium and Lactobacilli predominantly utilise NDO’s to 
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the benefit of the hosts health (Scholz-Ahrens et al. 1998). Common NDO’s utilised 
as prebiotics include inulin, fructooligosaccharides and galactooligosaccharides. Due 
to the potential interaction between prebiotics and probiotics, food products that 
contain a mixture of both have been referred to as synbiotics, and are becoming 
more prevalent (Mattila-Sandholm et al. 2002; Gibson et al. 2004).  
 
1.2.1. Health benefits of non-digestible oligosaccharides 
Oligosaccharides have been shown to exhibit a number of health benefits, and 
studies have shown that they:  
 Modify the microflora of the GIT. NDO’s are selectively fermented by 
Bifidiobacterium which inhibit the growth of pathogenic bacteria (Gibson et al. 
2004; Roberfroid et al. 2010). 
 Increase the rate of synthesis of vitamin B in the GIT by Bifidiobacterium 
(Perugino et al. 2005). 
 Can reduce adhesion of toxins produced by pathogenic bacteria in the GIT as 
well as the adhesion of these bacteria, protecting the host against illnesses 
(Sinclair et al. 2009; Searle et al. 2010; Quintero et al. 2011). 
 Relieve symptoms of constipation in a similar manner to dietary fibre 
(Delzenne and Roberfroid 1994; Roberfroid and Slavin 2000; Mussatto and 
Mancilha 2007). 
 Reduce cholesterol, phospholipid and triglyceride levels in blood of hosts, 
resulting in a decrease in the risk of diabetes and obesity (Alliet et al. 2007; 
Hanning et al. 2010; Roberfroid et al. 2010; Sanz and Santacruz 2010). 
 Inhibit diarrhoea associated with GIT infections possibly due to the inhibiting 
effect of Bifidiobacterium on pathogenic bacterial species (Roberfroid and 
Slavin 2000; de Vrese and Offick 2010). 
 Increase the rate of calcium absorption in the GIT as well as the rate of bone 
mineralisation, resulting in decreased risk of osteoporosis (Chonan et al. 
1995; Scholz-Ahrens et al. 1998, 2001; Mussatto and Mancilha 2007). 
 Reduce the risk of developing intestinal cancer through the reduction of 
carcinogenic precursors (Guarner and Malagelada 2003; Bruno-Barcena and 
Azcarate-Peril 2015). 
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1.3. β-Galactosidase: a multifunctional enzyme 
 
β-Galactosidases hydrolyse the non-reducing β-D-galactose ends of di- and 
oligosaccharides and are found in both eukaryotic and prokaryotic organisms (Table 
3), performing a variety of different functions (Richmond et al. 1981; Bhatia et al. 
2002; Husain 2010). They are secreted by microorganisms such as fungi, bacteria 
and yeast to hydrolyse oligosaccharides to fermentable monosaccharides 
(Richmond et al. 1981; Husain 2010). In plants they are found in a variety of tissues, 
playing roles in plant growth and fruit ripening (Li et al. 2001) and are also located in 
the membrane of the small intestines of mammals where they hydrolyse lactose into 
glucose and galactose (Mahoney 1997).  
 
Table 3: Selection of the numerous sources of β-galactosidases in nature (Adapted from Mahoney, 
1997; Richmond et al, 1981) 
Plants Mammal 
Organs 
Bacterial Species Fungal Species 
Apricots 
Coffee Beans 
Peaches 
Alfalfa seeds 
Almonds 
Apples 
Liver 
Brain 
Intestines 
Arthrobacter sp. 
Streptococcus thermophilus 
Streptococcus lactis 
Escherichia coli 
Thermus aquaticus 
Bacillus coagulans 
Bacillus megaterium 
Bacillus circulans 
Lactobacillus bulgaricus 
Lactobacillus helareticus 
Alternaria alternata 
Aspergillus oryzae 
Aspergillus niger 
Aspergillus foetidus 
Kluyveromyces lactis 
Kluyveromyces fragilis 
Kluyveromyces bulgaricus 
Mucor meuhei 
Mucor pucillus 
Neurospora crassa 
Rhizobium meliloti 
 
 
The Escherichia coli (E. coli) β-gal (EC 3.2.1.23) is arguably one of the best studied 
proteins in the world (Mahoney 1997; Juers et al. 2012). It was used by the scientists 
Jacob and Monod (1961) to develop their operon model, was fully sequenced in 
1970 (Fowler and Zabin 1978) and its three dimensional and crystal structures were 
determined in 1994 and 2001 respectively (Jacobson et al. 1994; Juers et al. 2001). 
Since the first crystal structure elucidation, the structures for β-gals originating from a 
variety of organisms have been determined and deposited in the Protein Data Bank 
(PDB, http://www.rcsb.org) (Table 4). It is utilised by molecular biologists throughout 
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the world as it forms a blue dye when grown with X-gal (5-bromo-4-chloro-3-indoyl-β-
galactopyranoside). This artificial substrate is a colourless substance which consists 
of a substituted indole linked to a galactose moiety. The β-gal enzyme is highly 
specific for the sugar within X-gal and, therefore, hydrolyses it causing the 
substituted indole to be released. This then dimerises, resulting in an insoluble blue 
product (Horwitz et al. 1964).  
 
Table 4: Selection of organisms whose β-galactosidases have been isolated and used to produce 
crystal structures (Berman et al. 2000) 
Organism GH Family PDB Code Reference 
Sulfolobus solfaticus GH1 1UWQ (Gloster et al. 2004) 
Escherichia coli GH2 1BGM (Juers et al. 2001) 
Arthrobacter sp. C2-2 GH2 1YQ2 (Skálová et al. 2005) 
Kluyveromyces lactis GH2 3OBA (Pereira-Rodríguez et al. 2012) 
Penicillium sp. GH35 3D3A (Rojas et al. 2004) 
Trichoderma reesei GH35 3OG2 (Maksimainen and Rouvinen 2011) 
Homo sapiens GH35 3THC (Ohto et al. 2012) 
Thermus thermophilus A4 GH42 1KWG (Hidaka et al. 2002) 
Bacillus circulans sp. alkalophilus GH42 3TTS (Maksimainen et al. 2012) 
 
E. coli β-gal is a 464 kDa homotetrameric enzyme, each subunit of which consists of 
1023 amino acids (Appel et al. 1965; Fowler and Zabin 1978; Kalnins et al. 1983). 
Individual subunits contain five different structural domains (Jacobson et al. 1994; 
Juers et al. 2000). The third of these domains contains the active site which is 
formed by a α8β8 barrel (Juers et al. 2012), although there are a number of residues 
in the other domains that play critical roles in the activity of the enzyme. The catalytic 
reaction of β-gal is dependent on two amino acid residues; one acting as an acid or 
proton donor and the other as the nucleophile or base (Juers et al. 2012). In E. coli 
these two residues have both been shown to be glutamic acid (Glu461 and Glu537) 
which act as the proton donor and nucleophile, respectively (Bader et al. 1988; 
Gebler et al. 1992). 
 
The Carbohydrate Active Enzymes database (CAZy, http://www.cazy.org) is an 
online resource where enzymes that are active on carbohydrates have been divided 
into five classes – glycoside hydrolases (GH), carbohydrate-binding molecules, 
glycosyltransferases, carbohydrate esterases, and polysaccharide lyases (Cantarel 
et al. 2009). The amino acid sequences of β-gals originating from a large number of 
different sources have been determined. Multiple sequence alignments indicate that 
Stellenbosch University  https://scholar.sun.ac.za
22 
 
there are a number of highly conserved regions throughout these enzymes that have 
been utilised to divide them into groups with similar enzymatic activity (Henrissat 
1991; Henrissat and Bairoch 1993, 1996; Davies and Henrissat 1995; Henrissat and 
Davies 1997). Owing to the correlation between sequence similarity and protein 
folding, classifying enzymes in this manner illustrates their structural characteristics 
more accurately than utilising only substrate specificity. It also provides scientists 
with a means of predicting the enzymatic mechanism of a protein and allows them to 
determine evolutionary relationships between different polypeptides. Glycoside 
hydrolases, which include β-gals, are currently classified into 133 different families 
(Lombard et al. 2014). β-Gals are classified within four of these, namely GH1, GH2, 
GH35 and GH42, based on sequence similarity. Those belonging to the GH1, GH2 
and GH42 families have mainly been found in microorganisms (Kalnins et al. 1983; 
Cubellis et al. 1990; Ohtsu et al. 1998), whereas β-gals in GH35 have been identified 
in plants, animals and microorganisms (Oshima et al. 1988; Smith and Gross 2000; 
Zinin et al. 2002). Over and above β-gal activity, enzymes that fall into the GH1 
family also possess β-glucosidase, β-mannosidase and β-glucuronidase activities. 
GH2 enzymes possess all of those activities as well as an additional α-
arabinofuranosidase activity. Proteins classified in GH32 possess exo-β-
glucosaminidase and exo-β-1, 4-galactanase activities while GH42 family enzymes 
possess α-arabinopyranosidase activity (Lombard et al. 2014).  
 
β-Galactosidases are capable of hydrolysing a large number of different substrates 
as the enzyme is specific only for the β-D-galactose moiety (Brockhaus et al. 1979; 
Nam Shin et al. 1980). This leads to a degree of promiscuity by these enzymes when 
another molecule is present in the non-galactose position, resulting in a large 
number of aglycones being utilised by them as substrates. β-Gals can also form 
oligosaccharides under specific conditions through a process known as 
transglycosylation (Wallenfels 1951; Aronson 1952; Pazur 1953). They catalyse the 
reaction between a donor that contains a galactose moiety and an acceptor that 
contains an -OH group (Figure 1) through a double displacement mechanism where 
a covalent glycosyl-enzyme intermediate forms. When using lactose, this reaction 
proceeds in three steps: 
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 Step 1: the enzyme binds to lactose forming an enzyme-lactose complex. 
 Step 2: glucose is released, while galactose remains covalently bound to the 
enzyme (intermediate form). 
 Step 3: the bound galactose is released when an acceptor nucleophile 
containing a –OH group accepts the galactose molecule. When the 
nucleophilic acceptor is water, galactose is released as the final product 
(Acceptor 1; Figure 1). When the acceptor is a saccharide, the galactose and 
saccharide are bound together through the formation of a glycosidic bond, 
and an oligosaccharide is released (Acceptor 2, 3 or 4; Figure 1). As 
carbohydrates of different degrees of polymerisation present in the 
environment around the enzyme can fill the role of nucleophilic acceptor, the 
results of this transglycosylation reaction can vary between short chain 
oligosaccharides and long chain polymers. 
 
 
Figure 1: Mechanism of hydrolysis and transglycosylation of lactose. Different acceptors result 
in the formation of various end-products (Gosling et al. 2011; Wang et al. 2012). 
A number of studies have been conducted to show that GOS yield increases with 
increasing initial lactose concentrations (Roberts and Pettinati 1957; Huber et al. 
1976). This property has been observed both in enzymes that tend to favour 
hydrolysis over transglycosylation (such as the E. coli β-gal) (Aronson 1952), as well 
as those that produce large quantities of GOS (Boon et al. 2000a; Hansson and 
Adlercreutz 2001b). Two hypotheses exist that can be used to explain this 
observation – a reduction in competitive hydrolysis of oligosaccharides already 
formed or an increase in the rate of the transferase reaction. This could be explained 
by the reduction of water activity as a result of the high substrate concentrations, 
leading to reduced hydrolysis (Maugard et al. 2003; Gaur et al. 2006; Martínez-
Villaluenga et al. 2008b). The second hypothesis predicts that increased initial 
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substrate concentrations make carbohydrate acceptors more available, resulting in 
an increase in oligosaccharide synthesis (Huber et al. 1976; Burvall et al. 1979; 
Akiyama et al. 2001; Hsu et al. 2007). It has also been shown that the linkage and 
degree of polymerisation produced during transglycosylation is dependent on a 
number of variables such as the source of the enzyme, pH, presence of enzymatic 
co-factors and reaction time (Mahoney 1997; Boon et al. 2000a; Tzortzis and Vulevic 
2009; Gosling et al. 2010, 2011; Park and Oh 2010b; Wang et al. 2012). The various 
activities that β-gals possess, as well as their presence in many different species 
have led to their use in industry as biocatalysts. 
 
1.4. Biocatalysts 
1.4.1. Definition and characteristics of biocatalysts 
Enzymes are becoming used more extensively as catalysts to generate products of 
interest such as biopolymers, biofuels and pharmaceuticals (Cobb et al. 2013). 
Characteristics of biocatalysts that can be utilised on an industrial scale include the 
need to have a high rate of catalytic turnover, stability under industrial conditions and 
stringent selectivity towards the formation of the product of interest (Panke et al. 
2004; Pollard and Woodley 2007; Fox and Clay 2009; Turner 2009). Although these 
enzymes can perform complicated chemical reactions efficiently, industrial conditions 
differ from those found in nature with regard to temperature, substrate 
concentrations, presence of organic solvents and sheering forces (Otten and Quax 
2005). The majority of native enzymes do not function optimally under these 
conditions and, therefore, cannot be utilised. Industrial biocatalysts with a desired 
activity can be acquired through optimising the conditions under which the reaction 
takes place, as well as through protein engineering to obtain a better biocatalyst 
(Otten and Quax 2005).  
 
1.4.2. β-Galactosidase as a biocatalyst 
β-Galactosidases are widely utilised by the food industry as biocatalysts to remove 
or reduce lactose from milk products for consumption by lactose intolerant 
individuals (Haider and Husain 2008). High concentrations of this sugar in 
refrigerated products are undesirable due to its tendency to form crystals that confer 
a sandy texture. By lowering the lactose content with β-gal, unwanted crystal 
formation can be reduced (Panesar et al. 2006). The addition of β-gal to whey 
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hydrolyses the lactose that is present into glucose and galactose, converting an 
environmental pollutant into a sweet syrup that can be utilised by the soft drink, 
baking and dairy industries as a replacement to starch or sucrose based sweeteners 
(Shukla 1975; González Siso 1996; Gänzle et al. 2008).  
 
Although there is an abundance of sources for β-gals available for scientists to study 
and characterise, those from only a small number of species have been utilised in 
the food and dairy industry. This is due to strict regulations requiring that any 
enzyme utilised in the food industry must be isolated from generally regarded as safe 
(GRAS) microorganisms (Mahoney 1997). Currently scientists and food 
technologists are trying to make use of recombinant DNA technology as a means of 
manufacturing β-gals with higher transglycosylation activity than current 
commercially available β-gals. This is being done using enzymes originating from 
microorganisms that are not GRAS in hosts such as Saccharomyces cerevisiae, 
although these products will still have to undergo comprehensive testing to ensure 
they are safe for consumption before being released (Mahoney 1997; Husain 2010; 
Oliveira et al. 2011). Due to these strict regulations, β-gals that are currently utilised 
in a commercial setting come from the yeasts Kluyveromyces lactis, Kluyveromyces 
fragilis and Candida pseudotropicalis, bacteria such as Streptococcus thermophilus 
and Bacillus stearothermophilus as well as fungal species such as Aspergillus niger, 
Aspergillus oryzae, Cryptococcus and Bullera (Table 5) (Mahoney 1997; Labrou 
2005; Tzortzis and Vulevic 2009; Otieno 2010; Park and Oh 2010b). Clearly the β-
gals that are currently used as industrial biocatalysts can be improved which has led 
scientists to undertake protein engineering as a way to enhance the 
transglycosylation activity of commercially available β-gals. 
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Table 5: Some sources of commercial β-galactosidases and their suppliers (Panesar et al. 2006). 
Source Organism Supplier GRAS 
Bacteria   
Bacillus sp. Novozyme, Denmark Yes 
Escherichia coli Sigma-Aldrich, UK No 
Yeast   
Kluyveromyces sp. SNAM Progetti, Italy 
Sigma-Aldrich, UK 
Yes 
Candida pseudotropicalis Novozyme, Denmark 
Pfizer, USA 
Yes 
Saccharomyces fragilis Sigma-Aldrich, UK Yes 
Fungi   
Aspergillus niger Sumitomo Chemical, Japan 
Valio Labs, Finland 
Megazyme, Ireland 
Yes 
Aspergillus oryzae Biocon, USA 
Sigma-Aldrich, UK 
Yes 
 
1.5. Protein engineering of β-galactosidases 
Recently biocatalysts have been altered through the process of protein engineering 
to optimise and increase the rate of production of the product of interest. This is the 
process whereby the DNA sequence of a gene is altered, resulting in an alteration in 
structure and activity of the protein it encodes (Farinas et al. 2001; Dougherty and 
Arnold 2009; Socha and Tokuriki 2013). There are a number of different methods 
that can be utilised to achieve this, which can be divided into random or targeted 
approaches (Lutz and Patrick 2004; Neylon 2004; Hibbert et al. 2005; Jäckel et al. 
2008). Methods to induce random changes in the DNA sequence include the use of 
bacterial mutator strains that are deficient in DNA repair pathways, use of mutagens 
(such as UV radiation) to alter the DNA sequence, or error-prone PCR. Targeted 
approaches can be accomplished using commercially available kits that alter the 
nucleotide sequence resulting in the deletion, insertion or alteration of specific amino 
acids (Jäckel et al. 2008).  
 
Initially, scientists utilised protein engineering to determine the location of residues, 
in E. coli LacZ protein, that were essential for catalysis. This was done by introducing 
point mutations and observing the change in hydrolytic activity with chromogenic 
substrates such as ortho-nitrophenyl-β-galactoside (oNPG). As more became known 
about the structure, function and characteristics of GH enzymes, focus has shifted to 
Stellenbosch University  https://scholar.sun.ac.za
27 
 
mutating these enzymes to increase specific activities, alter substrate specificities, 
confer increased tolerance to heat and pH changes, reduce substrate and product 
inhibition, or change the final product of an enzyme (Kittl and Withers 2010; Teze et 
al. 2014). Although our understanding of the mechanisms behind enzymatic 
reactions continues to grow, rational design of enzymes is a highly complex process 
as it is limited by comparing potential changes to protein structure models that have 
been determined by X-ray crystallography or nuclear magnetic resonance (NMR) 
spectroscopy (Kittl and Withers 2010). Changes in conformation of enzymes 
continuously occur during catalysis, resulting in deviation from modelled or predicted 
protein structures making rational design with the aim of altering activity a hit and 
miss affair (Jäckel et al. 2008; Li et al. 2012; Kries et al. 2013). This has led to 
researchers combining rational design and directed evolution to achieve the 
alterations that they are selecting for (Chica et al. 2005). 
 
As the importance of oligosaccharides increases throughout industry, there has been 
a concerted effort by scientists to increase the rate of their synthesis through a 
targeted approach (Perugino et al. 2004). The main problem with using GH enzymes 
to produce them is that they have a tendency to favour the hydrolysis over the 
transglycosylation reaction. This leads them to both manufacture and degrade 
oligosaccharides, resulting in low yield. In an attempt to stop the hydrolysis reaction 
a novel class of enzyme was developed, known as a glycosynthase (Mackenzie et 
al. 1998). Through site-directed mutagenesis (SDM), the hydrolytic activity of a β-
glycosidase from Agrobacterium tumefaciens was completely inactivated. This was 
achieved by mutating the codon responsible for the amino acid that acts as the 
catalytic nucleophile into one that encoded a non-nucleophilic residue (Table 6). In 
the presence of an external nucleophile such as sodium azide, activity is restored. 
Through the use of activated glycosyl donors (e.g. α-glycosyl fluoride) as substrates 
and external nucleophiles, oligosaccharides accumulate that cannot be hydrolysed 
by the glycosynthase.  
 
Although glycosynthases can produce relatively large quantities of oligosaccharides, 
the requirement of activated substrates has limited their widespread use in industry 
as there is a preference to utilise cheaper substrates such as lactose (Perugino et al. 
2004). This has led scientists to engineer GH enzymes with an increased synthetic 
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activity that can utilise these cost effective substrates. A protein engineering 
approach was used to increase the rate of oligosaccharide synthesis by a β-
glucosidase originating from Pyrococcus furiosus (Hansson and Adlercreutz 2001a; 
Hansson et al. 2001). Through altering amino acids in the active site of the enzyme, 
an increase in the total amount of oligosaccharides synthesized at low substrate 
concentrations as well an increase in the transglycosylation/hydrolysis ratio was 
observed (Table 6). 
 
Feng et al. (2005) conducted studies on converting a GH1 β-glycosidase from 
Thermus thermophilus into a β-transglycosidase through both random and site-
directed mutagenesis. A multistep screening process consisting firstly of isolating 
mutants displaying a reduction in hydrolytic activity and then selection of colonies 
that retained transglycosylation activity was performed. Using this Feng et al. (2005) 
were able to isolate and characterise a number of clones that exhibited increased 
transglycosylation/hydrolysis ratio (Table 6). 
 
The mutation sites that Feng et al. (2005) and Hansson et al. (2001a) identified in 
their studies were utilised to investigate whether transglycosylation could be 
increased in a GH family 1 β-gal belonging to another organism, Sulfolobus 
solfataricus (Wu et al. 2013). Multiple sequence alignments showed that the sites 
were conserved throughout the GH family 1, and they separately altered the 
phenylalanine at position 359 to glutamine, as well as altering the phenylalanine at 
position 441 to tyrosine. The Phe359Gln and Phe441Tyr mutations increased total 
GOS yield to 58.3% and 61.7% respectively, from 50% total GOS yield utilising the 
WT protein (Table 6). Further analysis of the oligosaccharides produced by the 
transglycosylation reactions of the mutants compared to the WT enzyme indicated 
that both mutants also had increased yields of tri- and tetrasaccharides.  
 
The enhancement of the transglycosylation process in conjunction with the reduction 
of hydrolytic activity by directed evolution strategies has not been fully explored, 
despite evidence that GH enzymes transglycosylation activity can be maintained 
while hydrolytic activity can be almost completely removed (Feng et al. 2005; Placier 
et al. 2009). Placier et al. (2009) explored this theory by randomly mutating the β-gal 
originating from Geobacillus stearothermophilus in an attempt to increase 
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oligosaccharide yields. The approach utilised was similar to Feng et al. (2005), 
whereby a multistep screening strategy based on the reduction of the hydrolysis of a 
potential transglycosylation product (lacto-sucrose) was used to identify mutants with 
increased transglycosylation/hydrolysis ratios. The screen yielded a number of 
mutants, all containing an arginine to lysine missense mutation at residue 109. Site 
saturation mutagenesis was carried out at that site, with all possible amino acid 
residues except methionine, asparagine and proline being produced. This site falls 
within a highly conserved region near the active site, and analysis of all the mutants 
demonstrated a decrease in hydrolysis. The arginine to tryptophan mutation at 
residue 109 resulted in the greatest increase in GOS yield (30%), as well as an 
overall decrease in product hydrolysis (Table 6).  
 
Table 6: Mutations in β-galactosidases that resulted in increased oligosaccharide yield. 
Enzyme source GH 
family 
Mutagenesis 
approach 
Sites mutated Oligosaccharide yield vs 
WT enzyme 
Reference 
Agrobacterium 
tumefaciens 
GH42 SDM Glu358Ala 29-54% increase in yield 
Complete loss of hydrolytic 
activity 
(Mackenzie et 
al. 1998) 
Pyrococcus furiosus GH1 
 
 
SDM Met424Lys 
 
 
Phe426Tyr 
 
Met424Lys/ 
Phe426Tyr 
 
1% increase in yield 
compared to WT enzyme 
 
40-45% increase in yield 
 
40% increase in rate of 
synthesis at 10% (w/v) 
lactose concentration 
(Hansson and 
Adlercreutz 
2001a; Hansson 
et al. 2001) 
Thermus thermophilus GH1 Random 
Mutagenesis & 
SDM 
Phe401Ser 
 
Asn282Thr 
 
Phe401Ser/ 
Asn282Thr 
60-74% increase in yield 
 
Increase in rate of synthesis 
 
73% increase in yield 
(Feng et al. 
2005) 
Geobacillus 
stearothermophilus 
GH42 Random 
Mutagenesis & 
SDM 
Arg109Trp Decrease in product 
hydrolysis, resulting in 30% 
increase in GOS yield 
(Placier et al. 
2009) 
Sulfolobus solfataricus GH1 SDM Phe359Gln 
 
 
Phe441Tyr 
Increased total GOS yield to 
58.3% 
 
Increased total GOS yield to 
61.7% 
Overall increase in tri- and 
tetrasaccharide yield in both 
mutants  
(Wu et al. 2013) 
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1.5.1. Functional screening of a mutation library 
Screening for a specific type of activity plays a central role in the identification of 
clones of interest from a mutation library. The functional screening process entails 
the use of either end product identification or some form of complementation to allow 
identification of a sequence encoding a specific activity (Aharoni et al. 2005). A 
number of demands need to be met by a screening system for it to be considered 
effective. Firstly, it should selectively identify the property of interest (Schmidt-
Dannert and Arnold 1999; Aharoni et al. 2005). Secondly, the screening assay needs 
to be highly sensitive over a range of enzymatic activities so as to allow for 
identification and recovery of all improved clones – even if the improvement only 
results in a minor increase in activity when compared to the starting protein 
(Schmidt-Dannert and Arnold 1999). Finally, the screening system needs to be able 
to function in a high throughput format for it to be considered truly effective (Aharoni 
et al. 2005; Dougherty and Arnold 2009; Kittl and Withers 2010).  
 
Current commonly used screening systems rely on heterologously expressed 
biocatalysts in a host organism cultivated on agar plates utilising fluorophoric or 
chromophoric substrates to detect activity (Kittl and Withers 2010). An example of 
such a screening system is the detection of β-gal activity with the chromogenic 
substrate X-gal. Drawbacks to this approach include the fact that, currently very few 
substrates are available, meaning that only a small number of activities can be 
examined. In addition, the hosts genetic machinery can fail to identify transcription or 
translation signals which results in little or no protein expression, meaning that the 
presence of an activity of interest can be difficult to identify due to only faint colour 
changes (Uchiyama and Miyazaki 2009). 
 
Screening for transglycosylation activity is more complex than screening for other 
activities as there is currently no method to detect the formation of a glycosidic 
linkage (Kittl and Withers 2010). Oligosaccharide production by microorganisms is 
usually identified visually through a mucoid phenotype when cultivated on agar 
plates containing a substrate, or by evaluating the thickness or “ropiness” of a liquid 
culture (Vedamuthu and Neville 1986; Wahler and Reymond 2001; Ruas-Madiedo 
and de los Reyes-Gavilán 2005). These methods cannot be carried over to high-
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throughput applications either due to limited production of the oligosaccharide 
producing protein, or to the oligosaccharide not being secreted from the cell. 
 
A simple solution to overcome these problems is to utilise chemical dyes that 
selectively stain oligosaccharides. The fluorochrome aniline blue has been shown to 
possess a high affinity towards polysaccharides such as β(1→3), (1→4) and (1→6) 
glucans (Wood and Fulcher 1984), as well as β(1→3) and (1→6) galactans (Evans 
et al. 1984). It has been used successfully to detect the presence and formation of 
curdlan in bacterial, yeast and fungal colonies on agar plates (Nakanishi et al. 1976), 
and was used to screen a soil sample for bacterial strains producing glucans (Jung 
et al. 2007). Methylene blue on the other hand has been used previously to identify 
the presence of anionic polysaccharides in the red seaweed Gymnogongrus 
torulosus (Estevez et al. 2008), while Yariv phenylglycosides have been utilised to 
selectively stain β(1→3), (1→4) and α(1→4) glucans (Triplett and Timpa 1997), as 
well as the β(1→3) galactan of arabinogalactan proteins (Kitazawa et al. 2013). 
 
1.6. Problem definition 
Although there are numerous β-gals that produce GOS through the enzymatic 
transglycosylation of lactose, the activities of these enzymes are not optimal. The DP 
of the oligosaccharides that they produce are not very long, and they do not produce 
GOS in high enough quantities under industrial conditions to satisfy the need of 
manufacturers. This poses a serious problem to food scientists and biotechnologists, 
as the demand for GOS is steadily increasing due to their potential health benefits 
and an increase in consumer health awareness (Feick 2009; Ohr 2010). Two 
potential solutions to this problem are the screening of metagenomic libraries 
focussing on isolating and characterising novel β-gals with high transglycosylation 
activity; or utilising protein engineering to alter protein structure and function to 
increase the rate of transglycosylation of a β-gal that already produces GOS. This 
project aims to utilise both of these approaches to isolate β-gals with novel activities. 
 
A novel β-galactosidase (BGAL32) has been previously isolated within the Institute 
of Plant Biotechnology from a metagenomic library that was created with genomic 
DNA isolated from a milk contaminated soil sample obtained from a dairy farm (Prof. 
Jens Kossmann, Unpublished Results). This site was chosen as soil has been 
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shown to harbour a diverse mix of microorganisms (Streit et al. 2004; Curtis and 
Sloan 2005; Gans et al. 2006; Steele et al. 2008) and the presence of milk (and 
therefore lactose) would likely naturally enrich for microorganisms containing β-gals. 
Based on the mucoid colony morphology observed in cells expressing BGAL32, the 
clone appeared to encode an enzyme that produces oligosaccharides. The amounts 
and size of these oligosaccharides are, however, unknown. This project is aimed at 
identifying what carbohydrates BGAL32 produces from lactose and whether it is 
possible to mutate it to make it more useful to industry. 
 
Objectives of this study 
The objectives of this study are summarised below: 
 Biochemical characterisation of β-galactosidase protein to determine optimum 
conditions for activity 
 Random and site-directed mutagenesis of a oligosaccharide producing 
metagenomically derived β-galactosidase in order to:  
o increase the DP of the oligosaccharide that it produces 
o decrease the concentration of substrate required for oligosaccharide 
production 
 Analysis of oligosaccharide produced by the wild type and mutated β-
galactosidase 
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2. Materials and Methods 
 
2.1. Escherichia coli genotypes, plasmids and constructs 
DH5α (Invitrogen): F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoRnupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK
-mK
+), λ– 
DH5α Turbo ΔlacZ: F´ proA+B+ lacIq ∆lacZ fhuA2 ∆(lac-proAB) glnV gal R(zgb-
210::Tn10)TetS endA1 thi-1 ∆(hsdS-mcrB) (Kind gift of Mr Kyle Willard, Institute for 
Plant Biotechnology (IPB), Stellenbosch University, South Africa) 
XL1 Red (Agilent Technologies): F- endA1 gyrA96(naIR) thi-1 hsdR17 supE44 
relA1 lac mutD5 mutS mutT Tn10 (Tetr)a 
XL1 Blue (Agilent Technologies): endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 
F'[ ::Tn10 proAB+ lacIq Δ(lacZ)M15] hsdR17(rK
-mK
+) 
 
Table 7: Plasmids used in this study. 
Name Promoter Fusion Tag Signal Peptide Selection Origin 
pBluescript sk+ T7 promoter None None Amp Agilent 
Technologies, USA 
pRSET A T7 promoter His-Tag 
N-terminal 
None Amp ThermoFisher 
Scientific, USA 
pRSET::BGAL32 T7 promoter His-Tag 
N-terminal 
Present Amp Jens Kossmann, 
IPB* 
pRSET::E568Q T7 promoter His-Tag 
N-terminal 
Present Amp This study 
pRSET::W1092F T7 promoter His-Tag 
N-terminal 
Present Amp This study 
pRSET::lacZ T7 promoter His-Tag 
N-terminal 
Present Amp ThermoFisher 
Scientific, USA 
 
2.2. Plasmid DNA isolation 
Minipreps of plasmid DNA were conducted with the GeneJET plasmid miniprep kit 
(Fermentas, USA) following the manufacturer’s instructions. Maxipreps of plasmid 
DNA were conducted utilising the alkaline lysis maxiprep method of Sambrook and 
Russell (2000). 
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2.3. Preparation and transformation of competent cells 
Chemically competent E. coli cells were prepared according to the method 
developed by Hanahan (1991). Electrocompetent E. coli cells were prepared 
according to the method of Sambrook and Russell (2000). Plasmid DNA was 
transformed into competent E. coli DH5α ΔlacZ mutant either by the heat-shock 
method (Sambrook and Russell 2000) or using a Gene Pulser Xcell (BioRad, USA) 
for electrocompetent cells. Transformants were selected on LB agar plates [1% (w/v) 
tryptone, 1% (w/v) NaCl, 0.5% (w/v) yeast extract, 1.5% (w/v) bacterial agar, 40 
µg/ml X-gal, 0.1 mM IPTG] supplemented with appropriate antibiotics.  
 
2.4. Random mutagenesis 
E. coli XL1-Red was used to introduce random mutations following the 
manufacturer’s protocol. Briefly, XL1-Red competent cells were thawed on ice and 
1.7 µl β-mercaptoethanol was added to the competent cell mixture. Cells were 
incubated on ice for 10 minutes, with the contents gently mixed every 2 minutes. 
Plasmid DNA (30 ng) was added to the cells and incubated on ice for 30 minutes. 
Cells were then subjected to heat-shock at 42°C in a hot water bath for 45 seconds, 
and thereafter incubated on ice for 2 min. Pre-warmed (900 µl, 42°C) SOC medium 
[2% (w/v) tryptone, 10 mM NaCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose, 
0.5% (w/v) yeast extract] was added to the tube, and incubated at 37°C for 60 
minutes with shaking at 200 RPM. The transformation mixture (150 µl) was plated 
out onto LB agar plates [1% (w/v) tryptone, 1% (w/v) NaCl, 0.5% (w/v) yeast extract, 
1.5% (w/v) bacterial agar, supplemented with ampicillin (50 µg/ml)] and incubated for 
36 hours at 37°C. Colonies were picked at random from the transformation plates 
using sterile toothpicks to inoculate 260 3 ml LB broth [1% (w/v) tryptone, 1% (w/v) 
NaCl, 0.5% (w/v) yeast extract, supplemented with ampicillin (50 µg/ml)], and were 
incubated overnight at 37°C with shaking at 200 RPM. Individual cultures were 
utilised to ensure that there was no over-representation of a particular mutation; 
these were then pooled and a plasmid maxiprep was performed to isolate the 
plasmids (Sambrook and Russell 2000). 
 
2.5. Screening for oligosaccharide production 
Approximately 200 000 colonies were screened using the DH5α ΔlacZ mutant on 
SOB agar plates [2% (w/v) tryptone, 10 mM NaCl, 0.5% (w/v) yeast extract, 1.5% 
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(w/v) bacterial agar, 10 mM MgCl2, 10 mM MgSO4, 5% (w/v) lactose, 40 µg/ml X-gal, 
0.1 mM IPTG, supplemented with chloramphenicol (34 μg/ml) and ampicillin (50 
μg/ml)] containing varying amounts of lactose [between 5-20% (w/v)] and/or M9 
minimal media plates [1x Micronutrients (Appendix 6.1), 1x M9 salts (Appendix 6.2), 
5 mM MgSO4, 10 mg/L Biotin, 10 mg/L Thiamine-HCl, 1.5% (w/v) bacterial agar, 40 
µg/ml X-gal, 0.1 mM IPTG, 20% (w/v) lactose, supplemented with chloramphenicol 
(34 μg/ml) and ampicillin (50 μg/ml)] (Studier 2005). Chloramphenicol was added to 
the media as the LacZ gene has been replaced with a chloramphenicol resistance 
cassette in the E. coli DH5α ΔlacZ mutant. Plates were incubated at 28°C for a 
minimum of 7 days to allow for possible oligosaccharide production, which was 
visually identified by colony morphology associated with oligosaccharide production.  
 
2.6. Site-directed mutagenesis 
Site-directed mutagenesis was performed using the QuickChange II XL mutagenesis 
kit (Agilent Technologies, USA). Mutation primers were designed for specific sites in 
the BGAL32 gene (Table 8).  
 
Table 8: Mutagenic oligonucleotide primers utilised for site-directed mutagenesis. Nucleotides that 
were altered to change the amino acids are highlighted in bold and underlined. 
Desired 
mutation 
Forward Primer Reverse Primer 
E568Q CCTGTTGTACCTTCGCAATACTCGCACGCC
A 
TGGCGTGCGAGTATTGCGAAGGTACAACA
GG 
W1092F CGGGCGTGCACCAAAGCTGTTGTATCCGG
CTA 
TAGCCGGATACAACAGCTTTGGTGCACGC
CCG 
 
Site-directed mutagenesis was performed following the manufacturer’s instructions. 
PCR reactions were carried out under cycling conditions summarised in Table 9. 
Amplicons were digested with DpnI at 37°C for 1 hour to remove parental plasmid 
DNA. The digested PCR product was transformed into chemically competent E. coli 
(XL1 Blue), and plated out on LB agar plates [1% (w/v) tryptone, 1% (w/v) NaCl, 
0.5% (w/v) yeast extract, 1.5% (w/v) bacterial agar, 40 µg/ml X-gal, 0.1 mM IPTG, 
supplemented with ampicillin (50 μg/ml)] and incubated overnight at 37°C. The next 
day, single colonies were inoculated into LB broth [1% (w/v) tryptone, 1% (w/v) NaCl, 
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0.5% (w/v) yeast extract, supplemented with ampicillin (50 µg/ml)] and grown 
overnight at 37°C with shaking at 200 RPM. 
 
Table 9: Cycling parameters for mutation PCR. 
Segment Cycles Temperature Time 
1 1 95°C 1 min 
2 18 95°C 50 sec 
60°C 50 sec 
68°C 6 min 20 sec 
3 1 68 °C 7 min 
 
2.7. Sequencing 
Plasmid DNA of the mutation library was sequenced using a commercial company 
(Macrogen, South Korea). 
 
2.8. Heterologous protein expression in E. coli  
E. coli DH5α ΔlacZ cells containing expression plasmids [pRSET::BGAL32 (WT), 
pRSET A, pRSET::LacZ, pRSET::E568Q, pRSET::W1092F] were inoculated into 5 
ml LB [1% (w/v) tryptone, 1% (w/v) NaCl, 0.5% (w/v) yeast extract, supplemented 
with ampicillin (50 μg/ml)] and incubated overnight at 37°C with shaking at 200 RPM. 
The overnight culture was used to inoculate 200 ml ZYP-5052 auto-induction media 
[1% (w/v) N-Z amine, 0.5% (w/v) yeast extract, 50 mM Na2HPO4, 50 mM KH2PO4, 25 
mM (NH4)2SO4, 2 mM MgSO4, 0.2x Micronutrients, 0.5% (v/v) glycerol, 0.05 % (w/v) 
glucose, 0.2 % (w/v) lactose, supplemented with ampicillin (50 μg/ml)] (Studier 
2005). The culture was allowed to grow to saturation at 37°C with shaking at 250 
RPM. Cells were then sedimented by centrifugation (6000 x g, 15 minutes, 4°C). 
Crude protein was extracted from the cells by resuspending the pellet in 2.5 ml 
protein extraction buffer [100 mM HEPES-KOH buffer, pH 7.5, 20 μg/ml lysozyme], 
and cells were lysed by sonication for 10 seconds 4 times. Cell debris and unlysed 
cells were removed by centrifugation (16 000 x g, 20 minutes, 4°C). 
 
2.9. Determination of protein concentration 
Protein concentration was determined using the Bradford method (Bradford 1976), 
with Bovine Serum Albumin (BSA) as a standard. Crude protein was diluted down to 
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a working concentration of 10 µg/µl in protein extraction buffer [100 mM HEPES-
KOH buffer, pH 7.5].  
 
2.10. SDS-PAGE 
Crude protein extracts were visualised on Bis-Tris SDS-PAGE gels under denaturing 
conditions. Protein samples were mixed with equal volumes of loading dye [50 mM 
Tris-HCl, 0.02% (w/v) bromophenol blue, 1% (w/v) DTT, 10% (v/v) glycerol, 12.5 mM 
EDTA, 2% (w/v) SDS] and denatured by incubating samples at 70°C for 10 minutes 
before being loaded onto a 10% SDS-PAGE gel. Gels were run at a constant 120V. 
 
Gels were developed with colloidal Coomassie stain [0.02% (w/v) Coomassie 
Brilliant Blue G-250, 5% (w/v) Al2(SO4)3, 2% (v/v) orthophosphoric acid, 10% (v/v) 
ethanol], and excess stain was removed with destaining solution [2% (v/v) 
orthophosphoric acid, 10% (v/v) ethanol] (Dyballa and Metzger 2009). 
 
2.11. Enzyme activity determination 
β-gal activity was determined in a stopped assay examining glucose or galactose 
release from lactose. 10 µl of enzyme was incubated with 100 mM lactose at 30°C 
for 10 minutes. The reaction was stopped by boiling at 100°C for 5 minutes and 
amounts of released glucose and galactose were determined. Glucose was 
measured by incubating 20 µl aliquots with 180 µl of reaction buffer [150 mM Tris-
HCl (pH 8.1), 5 mM MgCl2, 1.5 mM NADP, 1.0 mM ATP]. Boiled protein was utilised 
as a negative control. The reaction was started by addition of 1.0 U/ml HK and 1.0 
U/ml G6PDH (Both from Megazyme, Ireland). Galactose was determined by 
incubating 20 µl aliquot with 180 µl buffer [150 mM Tris-HCl (pH 8.1), 1.5 mM NAD]. 
The reaction was started by addition of 1.0 U/ml GalDH and 1.0 U/ml GalM (Both 
enzymes from Megazyme, Ireland). Both reactions were followed by measuring the 
change in OD340 which was used to calculate the amount of sugar produced. 
Standard curves were prepared to determine the amount of sugar.  
 
2.12. Determining optimal pH for enzyme activity 
The pH optimum of the enzyme was determined by measuring glucose production 
(Section 2.11) in over a range of values from pH 5.0 to pH 10.0 [McIlvaine buffer, pH 
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5.0 to pH 6.0; MES-KOH, pH 6.0 to pH 7.0; HEPES-KOH, pH 7.0 to pH 9.0; Sodium 
carbonate, pH 9.0 to pH 10.0, all 100mM].  
 
2.13. Determining optimal temperature for enzyme activity 
The temperature optimum of the enzyme was determined by measuring glucose 
production (Section 2.11) over a range, from 4°C to 60°C. Assays were performed in 
100 mM lactose monohydrate for 10 minutes at the respective temperatures. 
Termination of the reactions was achieved by immersion in liquid N2, and 
subsequent boiling at 100°C for 5 minutes.  
 
2.14. Examination of enzymatic co-factors 
Various divalent metal ions were tested as possible inhibitory or stimulating agents 
on β-gal activity. This was achieved by incubating the enzyme with 100 mM lactose 
monohydrate in the presence of various 5 mM metal ions (Cu2+, Ca2+, Mg2+, Mn2+, 
Zn2+) and the chelating agent EDTA for 10 minutes at 30°C. The enzyme activity was 
compared to that of a blank control that had no co-factors added.  
 
2.15. Michaelis-Menten kinetics 
Michaelis-Menten kinetics for the enzyme was evaluated when the catalysed 
reaction followed a linear relationship, and determined by examining glucose 
production (Section 2.11) with increasing concentrations of lactose monohydrate 
from 5 mM to 200 mM. Kinetic constants Km and Vmax were determined utilising 
Michaelis-Menten non-linear regression plots.  
 
2.16. Enzymatic synthesis of oligosaccharides in an aqueous system 
To determine the optimal substrate concentration for GOS synthesis in an aqueous 
system, GOS synthesis was carried out with lactose monohydrate as a substrate in a 
total volume of 1 ml, over a range of lactose concentrations from 5 to 30% (w/v) at 
pH 8.0, crude protein (equivalent of 5 U β-gal activity), and 5 mM MgSO4. Samples 
were incubated for 24 hours at 30°C with shaking at 250 RPM, and then stored at -
20°C.  
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2.17. Oligosaccharide analysis 
2.17.1. Thin layer chromatography 
Supernatant from the enzymatic synthesis reaction was diluted to 7.5% (v/w) with 
ddH2O, and 0.25 µl was spotted with a pipette onto aluminium backed silica gel 60 
TLC plates (Merck, Germany), with butanol/ethanol/water (5:3:2, v/v/v) used as the 
mobile phase (Rabiu et al. 2001; Wang et al. 2012). Plates were developed by 
spraying a solution containing 0.5% (w/v) 3,5-dihydroxytoluene (Sigma-Aldrich, USA) 
and 20% (v/v) sulphuric acid and heating between two glass plates for 30 minutes at 
100°C (Wang et al. 2012). 
 
2.17.2. LC-MS 
Oligosaccharide samples were desalted utilising AG 1-X8 Formate and AG 50W 
resin (Bio-Rad, USA) packed spin columns. Columns were packed, and washed 
twice with 2 ml ddH2O at 1400 x g (2 minutes; 4°C). Carbohydrates were separated 
on a Waters Acquity UPLC system (Hewlett-Packard, USA), coupled to a Waters 
Synapt G2 QTOF (Hewlett-Packard, USA). Samples (2 µl) were injected and 
separated with a UPLC BEH Amide column (1.7 µm particle size; 2.1 x 150 mm; 35 
°C) at a flow rate of 0.17 ml/minute. Elution was over a gradient utilising ddH2O and 
acetonitrile as mobile phase, both containing 0.1% NH4OH. The gradient changed 
from 20:80 (v/v) to 50:50 (v/v) over 22 minutes. The column was then returned to 
initial conditions for 8 minutes to equilibrate. Electrospray ionization was operated in 
negative mode, under the following MS conditions: nebulizing gas (N2) pressure 260 
kPa, cone voltage of 40V. Data was analysed in MassLynx version 4.0 (Hewlett-
Packard, USA). Analytical grade standards were all purchased from Sigma-Aldrich 
(USA) unless stated otherwise: lactose (β-Gal-[1-4]-Gluc), 3' galactosyl-lactose (β-
Gal-[1-3]-β-Gal-[1-4]-Gluc) (Carbosynth, UK), maltotetraose (α-Gluc-[1-4]3-Gluc), 
maltopentose (α-Gluc-[1-4]4-Gluc), maltohexaose (α-Gluc-[1-4]5-Gluc), 
maltoheptahose (α-Gluc-[1-4]6-Gluc). 
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3. Results 
 
3.1. Bioinformatics analysis of BGAL32 
The BGAL32 (WT) gene was provided by Prof. Jens Kossmann (Institute for Plant 
Biotechnology, University of Stellenbosch) and encodes a β-gal isolated from 
screening a metagenomic library. Blastx (http://www.ncbi.nlm.nih.gov/BLAST/) 
analysis of the DNA sequence shows that it has significant similarity to a number of 
known β-gals. Its highest identity is with sequences from Proteiniphilum acetatigenes 
(WP_026327044.1) (79%), Porphyromonadaceae bacterium (WP_045090556.1) 
(73%), Elizabethkingia sp. (WP_047034341.1) (65%), Chryseobacterium piperi 
(WP_034681323.1) (63%) and Bacteroides acidifaciens (WP_044654332.1) (63%). 
These β-gals all belong to the GH2 family as they all contained the consensus 
sequence of the putative active site [LIVMFS]-W-[GSV]-x(2,3)-N-E, as defined by the 
Carbohydrate Active Enzymes database (CAZy, http://www.cazy.org). The predicted 
amino acid sequence of BGAL32 was aligned with sequences of bacterial GH family 
2 β-gals from Streptococcus thermophilus (WP_011226267.1), Escherichia coli 
(AAA24053.1), Arthrobacter sp. C2-2 (AJ457162.1) and Kluyveromyces lactis 
(GI:343781100) utilising ClustalW (http://www.ebi.ac.uk/clustalw) (McWilliam et al. 
2013) (Figure 2). Previous studies of the E. coli β-gal indicate that the general 
acid/base site is the glutamic acid at position 461 (Bader et al. 1988) while the 
glutamic acid at position 537 is the catalytic nucleophile (Gebler et al. 1992). 
Jacobson et al. (1994) reported that the glutamic acid at position 416 and the 
histidine at position 418 play roles in the binding of magnesium. Alignments of the 
bacterial GH2 enzymes indicate that these residues are fully conserved in BGAL32. 
The predicted molecular weight of the protein based on sequence analysis is 128.75 
kDa (CLC Main Workbench, Qiagen). SignalP 4.1 
(http://www.cbs.dtu.dk/services/SignalP) indicated the presence of a signal peptide 
which leads to secretion of the protein out of the cell after it is synthesised (Petersen 
et al. 2011). The signal peptide was not deleted from the pRSET::BGAL32 construct, 
nor any of the mutants.  
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Figure 2: Alignments of putative active sites and Mg
2+
 binging sites from BGAL32 and β-
galactosidases belonging to GH family 2. The predicted amino acid sequence of BGAL32 is 
compared to known GH2 β-gal sequences from Streptococcus thermophilus (WP_011226267.1), 
Escherichia coli (AAA24053.1), Arthrobacter sp. C2-2 (AJ457162.1) and Kluyveromyces lactis 
(GI:343781100). Grey arrows indicate the predicted catalytic acid/base site (E568) and the proton 
donor (E501); black arrows indicate predicted Mg
2+
 ligand binding sites (E455 and H457). Asterisks 
(*) indicate fully conserved residues, colons (:) indicate conservation between groups with highly 
similar properties, periods (.) indicate conservation between groups with dissimilar properties.  
3.2. Escherichia coli DH5α ΔlacZ mutant  
The functional β-gal enzyme can be split into two subunits, namely LacZα and 
LacZΩ. On their own these subunits are not active, but when both are present they 
recombine spontaneously to form an active enzyme (Juers et al. 2012). In many 
laboratory strains of E. coli there is a deletion of the LacZα subunit resulting in a non-
functioning enzyme, even though the LacZΩ is still present and expressed. By 
transforming a plasmid containing the LacZα fragment into the cell, a functional β-gal 
will be expressed which will result in colonies turning blue on X-gal. This 
phenomenon is the basis of blue/white screening - as there is a multiple cloning site 
in the plasmid that disrupts the LacZα gene, an insertion will result in a loss of β-gal 
activity. As this project specifically examines novel β-gals an E. coli DH5α ΔlacZ 
mutant, where the complete LacZ gene has been replaced with a chloramphenicol 
resistance cassette, was utilised. This means that although it will not display a blue 
phenotype on X-gal when transformed with a plasmid that contains sequence 
encoding the α-fragment, it will when complemented with the full LacZ gene (Figure 
3). 
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Figure 3: Demonstration of the lack of ability to complement lacZ mutations in E. coli strains 
DH5α and DH5α ∆lacZ. Cells were grown on LB agar containing X-gal. Deletion of the LacZ gene 
results in the loss of β-galactosidase activity, and as such the mutant does not display a blue 
phenotype when an α-complementation plasmid such as pBluescript is transformed into the cells. This 
activity can be reinstated by transforming the LacZ gene into the E. coli DH5α ΔlacZ mutant.  
3.3. Minimum lactose concentration required for plate based oligosaccharide 
production 
The minimal lactose concentration required for colony morphologies to visibly 
indicate oligosaccharides was investigated by spotting liquid cultures of E. coli DH5α 
ΔlacZ containing pRSET::BGAL32 onto plates supplemented with X-gal and varying 
concentrations of lactose. As can be seen in Figure 4, expression of BGAL32 results 
in a mucoid or slimy colony morphology that are associated with oligosaccharide 
production (Ruas-Madiedo and de los Reyes-Gavilán 2005) at 10%, 15% and 20% 
lactose (w/v), but not at 5% (w/v).  
 
 
 
 
 
Figure 4: Oligosaccharide production of BGAL32 on agar plates over a range of lactose 
concentrations. Oligosaccharide production can be seen from 10% (w/v) lactose and higher. All 
plates contained X-gal, and were incubated at 28°C for 7 days.  
DH5α ΔlacZ pRSET::LacZ 
DH5α ΔlacZ pBluescript 
DH5α pBluescript 
5% (w/v)  
10% (w/v) 
15% (w/v) 
20% (w/v) 
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3.4. Heterologous protein expression 
Crude protein extracts from the E. coli DH5α ΔlacZ mutant expressing different 
genes were separated by SDS-PAGE. The LacZ protein has an estimated molecular 
weight of approximately 116 kDa, while BGAL32 has an estimated molecular weight 
of approximately 130 kDa. Proteins of those sizes were observed in gels stained with 
Coomassie brilliant blue (Figure 5), and their presence is evident comparing colony 
phenotypes in Figure 12. Low levels of BGAL32 expression are observed when 
compared to expression levels of LacZ in the E. coli DH5α ΔlacZ mutant.  
 
Figure 5: Separation of crude protein extracts by SDS-PAGE. DH5α ∆lacZ cells containing 
vectors driving expression of lacZ or BGAL32 were grown and crude proteins were extracted by 
sonication. These were denatured and were separated on a 10% (v/v) Bis-Tris denaturing SDS-PAGE 
gel and stained with colloidal Coomassie brilliant blue. M: PageRuler prestained protein ladder. 
Negative control: empty pRSET A. LacZ: pRSET::LacZ. BGAL32: pRSET::BGAL32. Arrow indicates 
BGAL32. 
3.5. Enzymatic assays 
3.5.1. β-galactosidase activity of E. coli DH5α ΔlacZ mutant crude protein 
extracts 
Crude protein extracts were incubated with 100 mM analytical grade lactose to 
measure hydrolytic β-gal activity. The crude extracts of cells containing pRSET::LacZ 
and pRSET::BGAL32 exhibited β-gal activity, whereas those containing pRSET A did 
   M 
170 -  
100 -  
55 -  
40 -  
35 -  
25 -  
15 -  
10 -  
kDa 
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not. This indicates that the hydrolytic activity observed is due to heterologously 
expressed proteins that possess β-gal activity (Figure 6). 
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Figure 6: Determining background β-gal activity in the E. coli DH5α ΔlacZ mutant. 
Hexokinase/G6PDH assay to analyse background β-gal activity in the E. coli DH5α ΔlacZ mutant. 
pRSET::LacZ and pRSET::BGAL32 restored hydrolytic β-galactosidase activity; whereas pRSET A 
did not possess any activity indicating that there is zero background β-galactosidase activity in the E. 
coli DH5α ΔlacZ mutant.  
 
3.5.2. Biochemical characterisation of lactose degradation by BGAL32 
To examine the pH range under which the β-gal is active, assays were conducted in 
various buffers ranging from pH 5.0 to 10.0. Significant levels of β-gal activity were 
observed between pH 6.0 and 10.0, with maximal activity occurring between pH 7.5 
and 9.0. The optimum pH for enzyme activity being approximately pH 8.0 (Figure 7). 
  
Stellenbosch University  https://scholar.sun.ac.za
45 
 
5 6 7 8 9 10
0.00
0.25
0.50
0.75
1.00
pH
P
ro
te
in
 A
c
ti
v
it
y
(µ
m
o
l.
m
in
-1
m
g
 p
ro
te
in
-1
)
 
Figure 7: Effect of pH on enzyme activity. β-galactosidase activity was measured in different 
buffers from pH 5 to 10. Each data point represents 6 independent replicates ± S.E.M.  
The optimal temperature for enzyme activity was also assessed over a range from 
10°C to 60°C. Optimal enzyme activity was observed between 20°C and 40°C, with 
maximal activity being observed at 30°C (Figure 8).  
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Figure 8: Effect of temperature on enzyme activity. β-galactosidase activity was measured over a 
range of temperatures (10°C – 60°C). Each data point represents 6 independent replicates ± S.E.M. 
The effect of various enzymatic co-factors on β-gal activity was investigated by 
measuring activity in the presence of various divalent metal ions. The relative activity 
was determined by comparing activity to a control with no ions added. Ca2+ slightly 
inhibited enzyme activity, with Cu2+ and Zn2+ having much greater negative effects. 
Stellenbosch University  https://scholar.sun.ac.za
46 
 
Mg2+ and Mn2+ on the other hand increased the β-gal activity. The addition of EDTA 
to the reaction resulted in no change in β-gal activity (Table 10). 
 
Table 10: Influence of various co-factors on β-galactosidase activity. Activity was measured in the 
presence of various 5 mM divalent metal ions to determine if they inhibited or stimulated activity. 
Relative activity was determined by comparing β-gal activity to a blank sample that did not have any 
ions added. Each data point represents 6 independent replicates. 
Cation Relative Activity (%) 
Blank (none) 100 
EDTA 100  
Cu
2+
 41  
Ca
2+
 89  
Mg
2+
 137  
Mn
2+
 123  
Zn
2+
 24  
 
To determine kinetics for BGAL32, β-gal activity was measured in the presence of 
increasing concentrations of substrate (5 - 200 mM lactose) under optimum 
conditions (30°C, pH 8.0, 5 mM MgSO4). The protein displayed classical Michaelis-
Menten kinetics, with the Km and Vmax being 54.23 mM and 2.26 µmol/minute
-1/mg 
protein-1 respectively (Figure 9).  
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Figure 9: Velocity of BGAL32 at different lactose concentrations. Kinetic constants were 
determined by measuring β-galactosidase activity under optimal conditions over a range of lactose 
concentrations from 5 mM to 200 mM. Inset: Lineweaver-Burk plot. 
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3.5.3. Evaluating transglycosylation activity 
Transglycosylation activity of BGAL32 and the W1092F site-directed mutant was 
determined by comparing the amount of glucose and galactose released when crude 
protein extracts were incubated with lactose (Figure 10). If only hydrolysis was 
occurring, then it would be expected that there would be an equimolar release of 
glucose and galactose. Any discrepancy in this 1:1 ratio is as a result of the 
transglycosylation of galactose into oligosaccharides by the β-gal, and has been 
used by a number of authors to mathematically define the affinity of a β-gal to favour 
transglycosylation over hydrolysis (Torres et al. 2010; Palai et al. 2012; Frenzel et al. 
2015).  
 
As can be seen in Figure 10, both BGAL32 and W1092F are polymerising lactose 
via transglycosylation activity. When comparing the glucose/galactose ratios, the 
BGAL32 ratio is 1.54, and the W1092F ratio is 1.63. There were no statistically 
significant (P<0.05) differences in glucose and galactose release between the two 
enzymes, indicating that both have the same rate of transglycosylation. The ratios 
determined for BGAL32 and W1029F are comparable to the ratios observed by 
Frenzel et al. (2015) for GOS synthesis under similar reaction conditions with the β-
gal from Kluyveromyces lactis. 
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Figure 10: Glucose and galactose production of BGAL32 and W1092F mutant after incubation 
with lactose. 5U of β-gal was incubated in 100 mM lactose (pH 8.0), 5 mM MgSO4 at 30°C for 24 
hours, and then the glucose and galactose concentrations were determined.  
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3.6. Random mutagenesis of BGAL32 
A random mutagenesis library was created with the intention of screening for the 
production of oligosaccharides at low substrate concentrations using the E. coli XL1-
Red mutator strain. To determine the rate of mutation, plasmid DNA was isolated 
from 96 individual colonies and sequenced. Alignments of the resulting data with 
BGAL32 sequence allowed quantification of the rate and type of mutations. A total of 
28 kb of sequence was analysed, leading to the identification of 94 point mutations, 3 
insertions, and 2 deletions. This equates to 95.92% of total mutations being point 
mutations, 3.06% being insertions and 1.02% being deletions, with the overall rate of 
mutation determined to be 3.52 per kb. This falls within the mutation rate observed in 
experiments conducted by Greener et al. (1994; 1997).  
 
3.7. Functional screening of random mutagenesis library 
As BGAL32 did not exhibit the mucoid phenotype associated with oligosaccharide 
production at 5% (w/v) lactose concentrations, it was decided to screen the 
mutagenesis library at this concentration to isolate a clone that exhibited 
oligosaccharide formation. As BGAL32 was isolated from a metagenomic library that 
was screened in the E. coli ΔlacZ mutant, and it is known to be active in this strain of 
E. coli, it was decided to continue utilising it. Approximately 200 000 E. coli colonies 
were screened, however, no colonies were identified that produced oligosaccharide 
at these reduced lactose concentrations. The library was screened to completion, as 
170 900 colonies would be needed to theoretically screen for every possible 
mutation. Blue/white screening with X-gal was also utilised to assess mutations and 
loss of β-gal activity. Approximately 7% of the colonies exhibited a reduction in the 
intensity of the blue colour or complete loss of β-gal activity.  
 
3.8. Site-directed mutagenesis of BGAL32 
BGAL32 was mutated using the QuickChange II kit (Agilent Technologies, USA). As 
BGAL32 is metagenomically derived, to confirm that it belongs to the GH family 2 the 
predicted catalytic acid/base glutamic acid as determined by pairwise alignments 
with the E. coli LacZ gene at position 568 was mutated to a non-catalytic residue, 
glutamine, to try and inactivate activity. The other sequence that was mutated was 
chosen based on findings by Huber et al. (2003), where mutation of the tryptophan at 
position 999 in the E. coli LacZ gene resulted in alterations in the rate of 
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transgalactosylation due to the role it plays in stabilising the enzyme-glycosyl 
complex. Feng et al. (2005) showed that altering amino acids in these sites could 
lead to a reduction in the rate of hydrolysis, but increase the rate of 
transglycosylation. Mutants were confirmed by sequencing and alignments with 
BGAL32 (Figure 11).  
 
BGAL32     KGSDRPVVPSEYSHAMGNSSG 
LacZ       KGSDRPVVPSEYSHAMGNSSG 
E568Q      KGSDRPVVPSQYSHAMGNSSG 
 
BGAL32     KQQGVAGYNSWGARPLPEYSI 
LacZ       KQQGVAGYNSWGARPLPEYSI 
W1092F     KQQGVAGYNSFGARPLPEYSI 
 
Figure 11: Multiple sequence alignments of mutated plasmids. Predicted amino acid sequence 
alignments of E568Q and W1092F with BGAL32 and E. coli LacZ. Mutation sites are highlighted in 
grey.  
Mutated plasmids were transformed into E. coli DH5α ΔlacZ mutant, and grown on 
agar plates containing 20% (w/v) lactose (Figure 12) and M9 minimal media plates 
(Figure 13) containing different concentrations of lactose to observe alterations in 
phenotypes. 
 
 
Figure 12: Growth of mutants on SOB agar containing 20% (w/v) lactose and 20 µg/ml X-gal. 
BGAL32, LacZ and the W1092F mutant expressed in DH5α ∆lacZ able to hydrolyse X-gal, but only 
BGAL32 and W1092F exhibited a mucoid phenotype associated with oligosaccharide production. The 
E568Q mutation results in loss of β-galactosidase activity. pRSET was included as a negative control.  
  
BGAL32 
pRSET 
LacZ 
E568Q 
W1092F 
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Figure 13: Phenotypes of mutants on M9 minimal media at different lactose concentrations. 
BGAL32 produces oligosaccharides at lactose concentrations of 10% (w/v). E568Q mutant exhibits 
minimal growth when lactose is the sole carbon source as all hydrolytic activity has been removed. 
W1092F mutant has retained β-galactosidase activity, and exhibits a mucoid phenotype at 20% (w/v) 
lactose.  
As can be seen in Figure 12 and Figure 13, the E568Q mutation results in a loss of 
hydrolytic activity, leading to an inability to hydrolyze X-gal and minimal growth on 
M9 plates containing lactose as the sole carbon source. The W1092F mutant 
retained β-gal activity as it turns blue on agar plates containing X-gal and it has 
retained the ability to produce oligosaccharide based on colony morphology, 
however this is only observed at 20% (w/v) lactose.  
 
3.9. Oligosaccharide analysis 
3.9.1. Thin layer chromatography 
To investigate the effect of lactose concentration on GOS synthesis by BGAL32, 
crude protein extract with the equivalent of 5U of β-gal activity was incubated 
overnight at 30°C with lactose ranging from 5 – 30% (w/v). The majority of lactose 
became hydrolysed in all samples (Figure 14), but there was an increase in GOS 
formation as lactose concentrations increase.  
  
BGAL32 E568Q W1092F 
5%  
10%  
15%  
20%  
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Figure 14: TLC comparing the ability of BGAL32 to form oligosaccharide at different 
concentrations of lactose. Although BGAL32 can produce low amounts of GOS at 10% (w/v) 
lactose, increased amounts form as lactose concentrations increase. All reactions were carried out at 
30°C for 24 hours in increasing concentrations of lactose, pH 8.0, 5 mM MgSO4, 5U of β-gal. Glc: 
glucose; Gal: galactose; Lac: lactose; GGL: mixture of equimolar amounts of glucose, galactose and 
lactose. 
The ability of the two site-directed mutants to synthesize oligosaccharides was also 
investigated. An extract from cells expressing the null mutant E568Q neither 
hydrolyse lactose nor synthesises GOS while one from the W1092F mutant is still 
able to hydrolyse lactose although it appears to have reduced hydrolytic ability when 
compared to BGAL32 when comparing the intensity of the glucose and galactose 
spots on the TLC It also produces GOS at what appears to be greater concentrations 
than BGAL32 (Figure 15), although it is not clear if it produces GOS with a higher 
DP. 
  
Glc Gal Lac GGL 5% 10% 15% 20% 25% 30% 
 
GOS 
 
Initial Lactose Concentration (w/v) 
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Figure 15: TLC comparing oligosaccharide formation between BGAL32 and E568Q and 
W1092F site-directed mutants. All reactions were carried out at 30°C for 24 hours in 30% (w/v) 
lactose, pH 8.0, 5 mM MgSO4, 5U of β-gal. Glc: glucose; Gal: galactose; Lac: lactose; GGL: mixture 
of equimolar amounts of glucose, galactose and lactose. 
 
3.9.2. LC-MS 
To quantitatively assess the oligosaccharides being produced by the 
transglycosylation reaction of BGAL32 and the two site-directed mutants, LC-MS 
was utilised. Crude protein extracts were incubated overnight at 30°C in 30% (w/v) 
lactose with 5 mM MgSO4, and then desalted with anion/cation exchange columns. 
Samples were diluted and analysed on a QTOF in ESI negative mode. The total ion 
chromatogram shows that the W1092F mutant produces longer DP oligosaccharides 
in an aqueous GOS synthesis system than BGAL32, with the null mutant E568Q not 
having any β-gal activity at all (Figure 16). To illustrate that W1092F produces longer 
chain oligosaccharides than BGAL32, the mass for DP4 oligosaccharides has been 
extracted. As can be seen in Figure 17, only the W1092F mutant exhibits peaks 
above background levels on the chromatogram at this mass, indicating that it is the 
only sample that possesses oligosaccharides at this molecular mass.  
Glc Gal Lac GGL 
 
GOS 
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Figure 16: Total ion chromatogram illustrating seperation of oligosaccharides from aqueous 
incubation of crude protein extracts in lactose. All reactions were carried out at 30°C for 24 hours 
in 30% (w/v) lactose, pH 8.0, 5 mM MgSO4, 5U of β-gal.  
 
 
Figure 17: Extracted mass (665) indicating DP4 oligosaccharides. As can be seen above, 
BGAL32 and E568Q do not produce DP4 oligosaccharides but the W1092F mutant does. This 
indicates that the W1029F mutation was successful in increasing the DP of the oligosaccharide 
produced in the aqueous enzymatic incubation.  
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Table 11: GOS identified in LC-MS samples by their molar mass and retention times. 
Molar Mass (m/z) [M-H] Degree of polymerisation Retention time (min) 
179 Monosaccharides 7.6 – 8.0 
341 Disaccharides 11.60 – 12.05 
503 Trisaccharides 14.22 – 14.55 
665 Tetrasaccharides 16.50 – 16.89 
 
These results indicate that transglycosylation with BGAL32 produces a mixed 
population of oligosaccharides over a range of DP, and confirms that the W1092F 
mutant produces longer chain oligosaccharides than BGAL32 under aqueous 
conditions (Figure 17).  
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4. Discussion 
 
Galactooligosaccharides have been receiving increased attention due to their 
prebiotic activities, however, β-gals that are currently utilised to manufacture these 
oligosaccharides, tend to favour the hydrolytic reaction over the transglycosylation 
reaction. It was therefore decided to utilise both random and site-directed 
mutagenesis in an effort to increase the amount of oligosaccharide produced by a 
metagenomically derived β-gal belonging to the glycosyl hydrolase 2 family.  
 
4.1. Background of BGAL32 
Traditionally, β-gals that are used on an industrial scale for the hydrolysis of lactose 
and the formation of GOS are derived from Kluyveromyces, Aspergillus and Bacillus 
species (Husain 2010; Ansari and Satar 2012; Cruz-Guerrero et al. 2014). 
Furthermore, the majority of studies performed on β-gals are from cultured 
organisms. This means that a large potential source of enzymes has been ignored 
as it has been reported that up to 99% of microorganisms are unculturable under 
current laboratory conditions (Handelsman 2004; Xu 2006; Simon and Daniel 2009; 
Uchiyama and Miyazaki 2009; Iqbal et al. 2012), severely limiting the scope of 
scientists in terms of β-gals can be studied and utilised as biocatalysts. A 
metagenomic approach has been shown as a successful means to isolate 
biocatalysts with novel characteristics that can be utilised in a commercial setting 
(Steele et al. 2008), and has been utilised to isolate a diverse assortment including 
lipases, esterases, polysaccharide modifying enzymes, oxidoreductases and 
antibiotics (Henne et al. 2000; Rondon and Al 2000; Courtois et al. 2003; 
Schmeisser et al. 2003; Voget et al. 2003; Streit et al. 2004).  
 
BGAL32 was previously isolated from screening a metagenomic library that was 
created from genomic DNA isolated from a soil sample obtained from a dairy farm in 
an area where large volumes of milk runoff occurred. To determine the functionality 
of the clone, the sequence was analysed with various bioinformatic programs. The 
analysis showed similarity between BGAL32 and a number of bacterial β-gals, 
indicating putative conserved domains at the active site and sugar binding domain. 
Multiple sequence alignments of the BGAL32 amino acid sequence with those of 
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various bacterial GH family 2 β-gals allowed the identification of amino acids that act 
as the acid/base and nucleophile as Glu568 and Glu501 respectively, while the 
magnesium binding site was predicted to be Glu416 and His418 (Figure 2). These 
residues are conserved in all GH family 2 β-gals that were used for the alignment.  
 
4.2. Biochemical characterisation of BGAL32 
β-Gals are found throughout nature and they play a variety of different roles. The 
main activity that they are known for is their ability to hydrolyse lactose into glucose 
and galactose, but they also possess promiscuous activity on other substrates and 
they have the ability to form oligosaccharides (Wallenfels 1951; Juers et al. 2001, 
2012; Park and Oh 2010b). When observing the levels of heterologously expressed 
protein in the DH5α ΔlacZ mutant it is noted that BGAL32 exhibits low levels of 
expression. This is in all likelihood due to the presence of the signal peptide in the 
that exports the protein outside of the cell. However, there is still sufficient 
expression levels to synthesise oligosaccharide and restore β-gal activity to the 
DH5α ΔlacZ mutant as can be seen in Figure 4.The biochemical characterisation of 
BGAL32 was performed utilising 100 mM analytical grade lactose as a substrate. 
The majority of studies utilise artificial glycosides such as the chromogenic 
substance ONPG for characterisation (Table 12) and focus mainly on the hydrolytic 
action of the enzyme not its transglycosylation activity (Ly and Withers 1999; Gänzle 
et al. 2008; Gänzle 2012). As the investigation of transglycosylation is the main focus 
of this study it was decided to characterise BGAL32 utilising crude protein extract 
and lactose as a substrate; the E. coli DH5α ΔlacZ mutant lacks any background β-
gal activity, any activity observed utilising lactose as a substrate comes from 
heterologously expressed protein. 
 
The majority of β-gals exhibit bell-shaped pH activity curves (Ly and Withers 1999) 
over a broad range of pH values. β-Gals originating in fungi tend to exhibit maximal 
activity between pH 3.0 and 5.5, where β-gals isolated from bacterial and yeast 
sources are maximally active between pH 6.0 and 8.0 (Ly and Withers 1999; Husain 
2010; Ansari and Satar 2012). The pH curve of BGAL32 exhibited optimal 
functionality in the range of pH 7.0 and 9.0, similar to a number of β-gals that have 
been previously characterised (Table 12). The genomic DNA utilised to construct the 
metagenomic library was isolated from a location where milk runoff occurred at a 
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dairy farm and it is interesting to note that the optimal pH of BGAL32 is similar to 
those reported to be found in such runoff areas (Williamson et al. 1998; Ali et al. 
2007; Carvalho et al. 2013). The temperature at which BGAL32 displayed highest 
activity is in the general range of mesophilic organisms, with optimal activity in the 
range of 25°C to 40°C; similar to the β-gals from Arthrobacter sp. 32cB (30°C) 
(Pawlak-Szukalska et al. 2014), and two metagenomically derived β-gals (38°C and 
37°C, respectively) (Wang et al. 2010; Erich et al. 2015). 
 
It is commonly known that the E. coli β-gal as well as numerous other β-gals require 
divalent cations as enzymatic co-factors which activate the enzyme (Huber et al. 
1976; Harada et al. 1994; Sutendra et al. 2007). Investigations with BGAL32 
revealed that the enzyme was able to hydrolyse lactose in the presence of 10 mM 
EDTA indicating that hydrolytic activity is not inhibited by the chelation of divalent 
ions, however, β-gal activity was increased by the inclusion of Mg2+ and Mn2+. This is 
to be expected as the bioinformatic analysis of BGAL32 shows that there is an Mg2+ 
binding site in the enzyme (Figure 2). It is currently unclear exactly how the divalent 
cation activates enzymatic activity, but it is hypothesised its binding alters the 
conformation of the active site in such a way that the acid/base residue is located in 
the optimal position to allow nucleophilic attack of the bound glycosyl (Juers et al. 
2001; Lo et al. 2010). It was previously observed that BGAL32 did not produce 
oligosaccharides on agar plates that were not supplemented with Mg2+. This finding 
is supported by studies conducted on the E. coli β-gal transglycosylation reaction, 
which showed a significant decrease in transglycosylation in the absence of Mg2+ 
(Shifrin and Hunn 1969; Huber et al. 1976, 1979). Zn2+ and Cu2+ significantly 
inhibited β-gal activity to 42% and 21% respectively. Although it is not clear why that 
is the case, these cations could possibly interfere with substrate binding. Ca2+ 
inhibited the β-gal activity of BGAL32 by 10% and the overall concentration of 
calcium is relatively high in milk, however, the concentration of free Ca2+ ions in milk 
is low - approximately 2 mM – thus it may not result in high levels of inhibition on the 
enzymatic activity of BGAL32 if it was to be utilised to produce GOS from milk 
products (Gupta et al. 2012).  
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Table 12: Biochemical characteristics of several β-galactosidase enzymes. 1 unit of enzyme activity is 
expressed as 1 µmol of product per minute, and is determined under the optimal conditions for the 
enzyme. *Note: total protein activity – crude extract utilised to determine activity.  
Source organism Opt 
temp 
(°C) 
Opt 
pH 
Activity 
(ONPG) 
(U/mg) 
Activity 
(Lactose) 
(U/mg) 
Metal Ion 
Required 
GOS 
Synthesis 
Reference 
Metagenomic 30 8.0 - 1.5* Mg
2+
, Mn
2+
 Yes This study 
Metagenomic 50 7.0 314 32 - Yes (Wang et al. 2014) 
Metagenomic 65 8.0 148 2.76 Mn
2+
, Zn
2+
, 
Li
2+
 
Yes (Gupta et al. 2012) 
Metagenomic 78 6.8 185 47.6 Mg
2+
, Ca
2+
 No (Zhang et al. 2013) 
Metagenomic 38 7.0 243 86 Na+, K
+
, Ca
2+
 No (Wang et al. 2010) 
Metagenomic 37 7.0 - 6.7 Mg
2+
 No (Erich et al. 2015) 
Alicyclobacillus 
acidocaldarius 
65 5.5 13 - - No (Di Lauro et al. 2008) 
Arthrobacter sp. 
32cB 
30 8.0 213 42 Mg
2+
 Yes (Pawlak-Szukalska et al. 
2014) 
Bacillus 
megaterium 
55 7.5 60 - None Yes (Li et al. 2009) 
Bacillus 
stearothermophilus 
70 7.0 125 - K
+
, Mn
2+
 No (Chen et al. 2008) 
Bacillus 
licheniformis DSM 
13 
50 6.5 270 13.7 Na+, K
+
 Yes (Juajun et al. 2011) 
Caldicellulosiruptor 
saccharolyticus 
80 6.0 211 9.8 None Yes (Park and Oh 2010a) 
Deinococcus 
geothermalis 
60 6.5 38 11 - No (Lee et al. 2011) 
Geobacillus 
stearothermophilus 
65 6.5 0.5 0.34 - Yes (Placier et al. 2009) 
Halomonas sp. 
S62 
45 7.0 118.5 - Fe
2+
, Mn
2+
, 
Na
+
, Co
2+
, 
Ca
2+
 
No (Wang et al. 2013) 
Lactococcus lactis 15-
55 
6.0-
7.5 
36 - Mg
2+
, Fe
2+
 No (Vincent et al. 2013) 
Lactobacillus 
crispatus 
50 5.5-
6.5 
221 - Mg
2+
, Mn
2+
, K
+
 Yes (Nie et al. 2013)  
Pseudoaltermonas 
haloplanktis 
10 8.5 - 20.4 Mg
2+
, Mn
2+
, 
Ca
2+
, Li
+
 
No (Hoyoux et al. 2001) 
Kluyveromyces 
lactis 
40 7.0 560 124 Mg
2+
, Mn
2+
, 
Fe
2+
, Co
2+
, 
Ca
2+
 
Yes (Kim et al. 2003; 
Martínez-Villaluenga et 
al. 2008b) 
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The β-gal activity of BGAL32 exhibited classical Michaelis-Menten enzyme kinetics. 
The Km of the enzyme was determined to be 54.3 mM and the Vmax = 2.26 
µmol/minute-1/mg protein. This Km value is relatively high when related to results 
obtained for some other β-gals that have been characterised which range between 
approximately 1 and 17 mM (Li et al. 2009; Placier et al. 2009; Vincent et al. 2013; 
Zhang et al. 2013; Wang et al. 2014; Erich et al. 2015). However, it is similar to that 
of a number of others (Di Lauro et al. 2008; Wang et al. 2010), as well as the 
commercial enzymes originating from Aspergillus niger and Aspergillus oryzae which 
range between 36 – 100 mM (De Roos 2004).  
 
4.3. Mutagenesis of BGAL32 
When a plasmid encoding BGAL32 was expressed in E. coli, the cells demonstrated 
a mucoid phenotype when grown on plates with lactose concentrations greater than 
10% (w/v). This indicates that it produces GOS outside of the cell, albeit only when 
lactose concentrations are relatively high. In an attempt to increase the DP of the 
oligosaccharide produced by BGAL32, as well as decrease the concentration of 
lactose that is required to synthesise them, BGAL32 was randomly mutated using 
the E. coli XL1-Red strain. This strain lacks three of the primary DNA repair 
pathways – mutT (inability to hydrolyse 8-oxodGTP), mutD (deficient in 3´- to 5´-
exonuclease of DNA polymerase III) and mutS (error-prone mismatch repair). The 
mutation rate within this strain is 5000 times higher than that of wild-type E. coli 
(Greener and Callahan 1994; Greener et al. 1997; Wong et al. 2006), with mutations 
being introduced with each cycle of DNA replication. A number of studies have 
utilised XL1-Red (Coia et al. 1997; Lu et al. 2001; Terao et al. 2006; Callanan et al. 
2007; Rasila et al. 2009; Theriot et al. 2010) as it very fast and simple method to 
produce a gene library containing mainly point mutations. These are more desirable 
than insertions or deletions when the desire is to modify, rather than eliminate an 
activity, as they do not cause frameshifts and are less likely to result in the 
production of truncated proteins (Greener and Callahan 1994; Greener et al. 1997; 
Wong et al. 2006). Sequence analysis of the mutagenesis library indicated that the 
majority of the mutations were indeed point mutations. The library was screened on 
agar plates with 5% (w/v) lactose, which is also the approximate concentration of 
lactose present in bovine milk (Gänzle et al. 2008; Rodriguez-Colinas et al. 2014). 
Any clones encoding polypeptides that could synthesise oligosaccharides at this low 
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concentration would be highly favourable for use in the food industry and in the 
production of transglycosylated milk (Kunz and Rudloff 2006; Bauer et al. 2009; 
Rodriguez-Colinas et al. 2014). Despite screening 200 000 clones, none were found 
that appeared to produce oligosaccharides based on colony morphology. This could 
be due to the need for the alteration of more than one amino acid being required to 
alter the active site structure in a way that alters protein activity, the point mutations 
that occurred could be silent mutations, or a greater number of colonies need to be 
screened.  
 
As random mutagenesis of BGAL32 yielded no clones with improved properties, a 
site-directed mutagenesis approach was utilised in an attempt to produce new 
variants of BGAL32. This has been shown to be a valuable tool that scientists can 
utilise to determine structure/function relationships and has been successfully 
utilised by a number of groups to rationally design biocatalysts to increase their rate 
of production or alter their activity (Hinz et al. 2005; Perugino et al. 2005; Di Lauro et 
al. 2008; Park and Oh 2010b; Tran et al. 2010; Dong et al. 2011; Shumway and 
Sheridan 2012; Wu et al. 2013; Teze et al. 2014). Recently, a number of studies 
have been conducted on β-gals belonging to GH1 (Hansson and Adlercreutz 2001a; 
Hansson et al. 2001; Feng et al. 2005; Wu et al. 2013) and GH42 (Mackenzie et al. 
1998; Placier et al. 2009) families in an effort to increase the DP as well as the total 
amount of oligosaccharide that they produce by transglycosylation activity (see 
section 1.5 for more details, Table 6).  
 
Specific sites selected for the mutation of BGAL32 were identified from literature, as 
a number of studies have focused on altering oligosaccharide synthesis of glycosyl 
hydrolases. To confirm that BGAL32 belongs to the GH family 2 the predicted 
catalytic acid/base glutamic acid, as determined by pairwise alignments with the E. 
coli LacZ gene, at position 568 was mutated to glutamine. Glutamine is similar in 
size to glutamic acid and thus will not alter the structure of the protein or active site, 
however, it is unable to carry a charge as glutamic acid can. As expected all β-gal 
activity was lost in the mutated enzyme, similar to what occurs with the E. coli 
enzyme (Bader et al. 1988). This confirms the bioinformatic analysis that the 
metagenomically derived BGAL32 belongs to the GH family 2 enzymes.  
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In addition to the active-site residues, a number of other amino acids play roles in 
influencing enzymatic activity. These include those that orientate or stabilise the 
active site residues, as well as ones that are located close enough to the 
carbohydrate that they bind with it to form the intermediate enzyme-glycosyl complex 
(Ly and Withers 1999; Muraki 2002). The tryptophan at position 1092 is one of these 
amino acids and was selected based on findings by Huber et al. (2003), where 
mutation of the tryptophan at position 999 in the E. coli LacZ gene resulted in 
alterations in the rate of transgalactosylation. This residue is conserved in many GH 
family 2 β-gals and it has been determined that it helps to stabilise the enzyme-
glycosyl complex (Jacobson et al. 1994; Juers et al. 2000; Muraki 2002). This site 
was selected due to its location and role it plays in stabilising the enzyme-glycosyl 
complex; Feng et al. (2005) showed that altering amino acids in these sites could 
lead to reducing the rate of hydrolysis, but increase the rate of transglycosylation.  
 
4.4. Oligosaccharide analysis 
The transglycosylation activity of β-gals can be utilised to synthesise novel 
compounds through attaching galactose moieties to other chemicals or 
oligosaccharides, opening the possibility of applying these enzymes to produce  
molecules that possess biological activities such as GOS (Panesar et al. 2006). 
Currently, the production of GOS is achieved by batch fermentation production runs, 
utilising aqueous lactose solutions as substrate (Boon et al. 2000b; Gänzle et al. 
2008; Gänzle 2012; Lamsal 2012). The main drawback in utilising this method to 
synthesise GOS is that the reaction is shifted away from transglycosylation toward 
hydrolysis due to the high water content, ultimately resulting in low yield of GOS 
(Chen et al. 2001; Wang et al. 2012). This phenomenon was observed with BGAL32 
– the TLC data clearly indicates that hydrolysis takes place at all substrate 
concentrations that the enzyme was incubated with (Figure 14, Section 3.9.1). There 
have been several studies that have attempted to circumvent this problem with the 
addition of solvents to the reaction mixture which have shown that the reaction can 
be shifted towards transglycosylation (Shin and Yang 1994; Chen et al. 2001; 
Maugard et al. 2003; Wang et al. 2012). This still needs to be explored with BGAL32 
to determine whether a solvent-buffer system can be utilised to increase 
transglycosylation, and whether the protein will remain functional in the presence of 
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solvents as most β-gals are both less active and stable under those conditions (Shin 
and Yang 1994; Chen et al. 2001; Maugard et al. 2003; Wang et al. 2012).  
 
Transglycosylation of lactose can be easily identified by measuring the production of 
both glucose and galactose with enzymatically coupled assays. Hydrolysis of lactose 
alone results in equimolar amounts of glucose and galactose being released, 
however, when transglycosylation takes place relatively more glucose is liberated 
due to the galactose being used to produce oligosaccharides. Thin layer 
chromatography has also been widely utilised to qualitatively detect and visualise 
oligosaccharides (Jørgensen et al. 2001; Rabiu et al. 2001; Wang et al. 2012). It is, 
however, still possible to estimate the relative concentration of oligosaccharides 
produced by transglycosylation based on the intensity of the colour that develops 
from staining the TLC plate. As can be seen in Figure 14 there is an increase in GOS 
production with increasing initial lactose concentrations, as has also been observed 
with other β-gals (Chen et al. 2001; Maugard et al. 2003; Hsu et al. 2007; Gosling et 
al. 2011; Wang et al. 2012; Srivastava et al. 2015). This is most likely because 
increases in the initial concentration of lactose make acceptor and donor 
oligosaccharides more available than water to the enzyme, resulting in an increase 
in the hydrolysis/transglycosylation ratio (Gosling et al. 2011; Wang et al. 2012). The 
transglycosylation of BGAL32 was compared to the two mutant β-gals with TLC and 
it was observed that the W1092F mutant hydrolysed less lactose, but produced more 
oligosaccharides. The E568Q mutant has lost all hydrolytic activity, and thus only 
lactose is observed (Figure 15, Section 3.9.1). 
 
LC-MS has become a powerful analytical tool in the study of glycobiology and can be 
used to accurately quantitate the different oligosaccharide populations that are 
synthesised by transglycosylation (Dwek 1996; Stick and Williams 2008; Blow 2009; 
Coulier et al. 2009). As there is evidence that suggests that microorganisms 
propagate differently when fermenting different oligosaccharide structures, it is 
important to study and evaluate the structure of oligosaccharides if they are to be 
utilised as prebiotics (Gosling et al. 2010; Marín-Manzano et al. 2013). A large 
number of studies have shown that lactic acid bacteria and Bifidiobacteria 
preferentially utilise oligosaccharides with β1-6 glycosidic linkages over β1-4 
linkages (Gopal et al. 2001; Martínez-Villaluenga et al. 2008a, 2008c; Cardelle-
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Cobas et al. 2011). LC-MS has been utilised to determine the different linkages of 
oligosaccharides present in oligosaccharide samples. When comparing the total ion 
chromatograms of BGAL32 between the two site-directed mutants a difference can 
be seen. The E568Q mutant only has lactose present in the sample indicating a 
complete loss of hydrolytic activity, whereas the W1092F mutant produces longer DP 
oligosaccharides under aqueous reaction conditions than BGAL32, however, the 
structure of the DP4 oligosaccharide is yet to be elucidated. This result is significant 
as, in a commercial setting, GOS is typically synthesised by incubation of β-gal 
enzyme in a high concentration aqueous solution of lactose. Results from a previous 
study examining a β-gal belonging to the GH family 1 utilised the same sites for 
mutation between species of and achieved similar results (Wu et al. 2013). As this 
site is highly conserved amongst GH2 enzymes, further investigation is needed to 
determine whether or not this mutation will yield the same outcome with regard to 
oligosaccharide synthesis in other GH2 β-gals.  
 
5. Conclusion 
In conclusion, a metagenomically derived β-galactosidase that produced 
oligosaccharide on lactose was biochemically characterised to determine the optimal 
conditions under which it hydrolyses lactose. It was also subjected to random and 
site-directed mutagenesis in an effort to increase the amount of oligosaccharide it 
produced at low substrate concentrations. The random mutagenesis library was 
screened on agar plates containing 5% (w/v) lactose but no clones exhibiting 
oligosaccharide production were identified. Site-directed mutagenesis of BGAL32 
allowed confirmation of the bioinformatic classification of BGAL32 into the GH2 
family as the E568Q null mutant exhibited a loss in the ability to hydrolyse lactose. 
The W1092F oligosaccharide synthesis mutant exhibited an increase in the degree 
of polymerisation of the oligosaccharide that was produced in an aqueous GOS 
synthesis reaction, as well as an apparent increase in the amount of GOS produced. 
LC-MS experiments indicate that both BGAL32 and the W1092F mutant produce a 
mixed population of GOS through their transglycosylation activity on lactose, 
although these different structures need to be identified.  
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The findings presented in this thesis are significant, as studies that have been 
conducted on GH1 and GH42 β-galactosidases with the sole purpose of increasing 
the DP of the oligosaccharide that they produce have not been carried out on GH2 β-
galactosidases. Furthermore, research needs to be conducted to confirm whether or 
not the W1092F site is compatible with other β-galactosidases belonging to the GH2 
family, and whether or not this mutation will cause a similar increase in the DP and 
amount of oligosaccharide produced in an aqueous system for those enzymes.  
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6. Appendix 
6.1. Trace Metals Mix 
 
Chemical Final Concentration 
FeSO4 - 7H2O 50 mM 
CaCl2 20 mM 
MnCl2 - 4H2O 10 mM 
ZnSO4 - 7H2O 10 mM 
CoCl2 - 6H2O 2 mM 
CuSO4 - 5H2O 2 mM 
NiCl2 2 mM 
H3BO3 2 mM 
Na2SeO3 2 mM 
Na2MoO4 2 mM 
 
6.2. M9 Salts 
 
Chemical Final Concentration 
Na2HPO4 - 7H2O 47.7 mM 
KH2PO4 22 mM 
NaCl 8.5 mM 
NH4Cl 18.7 mM 
 
  
Stellenbosch University  https://scholar.sun.ac.za
66 
 
References 
Aharoni A, Griffiths AD, Tawfik DS. High-throughput screens and selections of enzyme-encoding 
genes. Curr Opin Chem Biol. 2005;9(2):210–6.  
Akiyama K, Takase M, Horikoshi K, Okonogi S. Production of galactooligosaccharides from lactose 
using a β-glucosidase from Thermus sp. Z-1. Biosci Biotechnol Biochem. 2001;65:438–41.  
Ali I, Barrington S, Bonnell R, Whalen J, Martinez J. Surface irrigation of dairy farm effluent, part II: 
System design and operation. Biosyst Eng. 2007;96(1):65–77.  
Alliet P, Scholtens P, Raes M, Hensen K, Jongen H, Rummens JL, et al. Effect of prebiotic galacto-
oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and 
triacylglycerol levels. Nutrition. 2007;23(10):719–23.  
Ansari SA, Satar R. Recombinant β-galactosidases - Past, present and future: A mini review. J Mol 
Catal B Enzym. Elsevier B.V.; 2012;81:1–6.  
Appel SH, Alpers DH, Shifrin S, Tomkins GM. Multiple molecular forms of β-galactosidase. J Mol Biol. 
1965;11(12 - 22).  
Aronson M. Transgalactosidation during lactose hydrolysis. Arch Biochem Biophys. 1952;39(2):370–
8.  
Badel S, Bernardi T, Michaud P. New perspectives for Lactobacilli exopolysaccharides. Biotechnol 
Adv. Elsevier Inc.; 2011;29:54–66.  
Bader DE, Ring M, Huber RE. Site-directed mutagenic replacement of Glu-461 with Gln in β-
galactosidase (E. coli): evidence that Glu-461 is important for activity. Biochem Biophys Res 
Commun. 1988;153(1):301–6.  
Bauer R, Bekker JP, Wyk N Van, du Toit C, Dicks LMT, Kossmann J. Exopolysaccharide production 
by lactose-hydrolyzing bacteria isolated from traditionally fermented milk. Int J Food Microbiol. 
Elsevier B.V.; 2009;131:260–4.  
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. 
Nucleic Acids Res. 2000;28:235–42.  
Bhatia Y, Mishra S, Bisaria VS. Microbial β-glucosidases: cloning, properties, and applications. Crit 
Rev Biotechnol. 2002;22(4):375–407.  
Blow N. A spoonful of sugar. Nature. 2009;457:617–20.  
Boon MA, Janssen AE., Van ’t Riet K. Effect of temperature and enzyme origin on the enzymatic 
synthesis of oligosaccharides. Enzyme Microb Technol. 2000a;26:271–81.  
Boon MA, Vant Riet K, Janssen AE. Enzymatic synthesis of oligosaccharides: Product removal during 
a kinetically controlled reaction. Biotechnol Bioeng. 2000b;70(4):411–20.  
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein 
utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.  
Brockhaus M, Dettinger H, Kurz G, Lehmann J, Wallenfels K. Participation of HO-2 in the cleavage of 
β-galactosides by the β-D-galactosidase from E. coli. Carbohydr Res. 1979;69:264–8.  
Stellenbosch University  https://scholar.sun.ac.za
67 
 
Bruno-Barcena JM, Azcarate-Peril MA. Galacto-oligosaccharides and colorectal cancer: Feeding our 
intestinal probiome. J Funct Foods. Elsevier Ltd; 2015;12:92–108.  
Burvall A, Asp NG, Dahlqvist A. Oligosaccharide formation during hydrolysis of lactose with 
Saccharomyces lactis lactase (Maxilact®): Part 1 -Quantitative aspects. Food Chem. 
1979;5:243–50.  
Callanan MJ, Russell WM, Klaenhammer TR. Modification of Lactobacillus β-glucuronidase activity by 
random mutagenesis. Gene. 2007;389(2):122–7.  
Cantarel BI, Coutinho PM, Rancurel C, Bernard T, Lombard V, Henrissat B. The Carbohydrate-Active 
EnZymes database (CAZy): An expert resource for glycogenomics. Nucleic Acids Res. 
2009;37:233–8.  
Cardelle-Cobas A, Corzo N, Olano A, Peláez C, Requena T, Ávila M. Galactooligosaccharides 
derived from lactose and lactulose: Influence of structure on Lactobacillus, Streptococcus and 
Bifidobacterium growth. Int J Food Microbiol. Elsevier B.V.; 2011;149:81–7.  
Carvalho F, Prazeres AR, Rivas J. Cheese whey wastewater: Characterization and treatment. Sci 
Total Environ. Elsevier B.V.; 2013;445-446:385–96.  
Chen SX, Wei DZ, Hu ZH. Synthesis of galacto-oligosaccharides in AOT/isooctane reverse micelles 
by β-galactosidase. J Mol Catal - B Enzym. 2001;16(2):109–14.  
Chen W, Chen H, Xia Y, Zhao J, Tian F, Zhang H. Production, purification, and characterization of a 
potential thermostable galactosidase for milk lactose hydrolysis from Bacillus 
stearothermophilus. J Dairy Sci. Elsevier; 2008;91(5):1751–8.  
Chica RA, Doucet N, Pelletier JN. Semi-rational approaches to engineering enzyme activity: 
Combining the benefits of directed evolution and rational design. Curr Opin Biotechnol. 
2005;16:378–84.  
Chonan O, Matsumoto K, Watanuki M. Effect of galactooligosaccharides on calcium absorption and 
preventing bone loss in ovariectomized rats. Biosci Biotechnol Biochem. 1995;59(2):236–9.  
Cobb RE, Sun N, Zhao H. Directed evolution as a powerful synthetic biology tool. Methods. Elsevier 
Inc.; 2013;60(1):81–90.  
Coia G, Ayres A, Lilley GG, Hudson PJ, Irving RA. Use of mutator cells as a means for increasing 
production levels of a recombinant antibody directed against Hepatitis B. Gene. 1997;201:203–
9.  
Coulier L, Timmermans J, Richard B, Van Den Dool R, Haaksman I, Klarenbeek B, et al. In-depth 
characterization of prebiotic galactooligosaccharides by a combination of analytical techniques. 
J Agric Food Chem. 2009;57(18):8488–95.  
Courtois S, Cappellano CM, Ball M, Francou F, Normand P, Martinez A, et al. Recombinant 
environmental libraries provide access to microbial diversity for drug discovery from natural 
products. Appl Environ Microbiol. 2003;69(1):49–55.  
Crittenden RG, Playne MJ. Production, properties and applications of food-grade oligosaccharides. 
Trends Food Sci Technol. 1996;7(11):353–61.  
Cruz-Guerrero A, Hernández-Sánchez H, Rodríguez-Serrano G, Gómez-Ruiz L, García-Garibay M, 
Figueroa-González I. Commercial probiotic bacteria and prebiotic carbohydrates: A fundamental 
study on prebiotics uptake, antimicrobials production and inhibition of pathogens. J Sci Food 
Agric. 2014;94(11):2246–52.  
Stellenbosch University  https://scholar.sun.ac.za
68 
 
Cubellis MV, Rozzo C, Montecucchi P, Rossi M. Isolation and sequencing of a new β-galactosidase-
encoding archaebacterial gene. Gene. 1990;94:89–94.  
Curtis TP, Sloan WT. Exploring microbial diversity - a vast below. Science (80- ). 2005;309:1331–3.  
Davies G, Henrissat B. Structures and mechanisms of glycosyl hydrolases. Structure. 1995;3(9):853–
9.  
Delzenne NM, Roberfroid MR. Physiological effects of non-digestible oligosacharides. LWT - Food Sci 
Technol. 1994;27:1–6.  
Dong Y-N, Liu X-M, Chen H-Q, Xia Y, Zhang H-P, Zhang H-P, et al. Enhancement of the hydrolysis 
activity of β-galactosidase from Geobacillus stearothermophilus by saturation mutagenesis. J 
Dairy Sci. Elsevier; 2011;94(3):1176–84.  
Dougherty MJ, Arnold FH. Directed evolution: new parts and optimized function. Curr Opin 
Biotechnol. 2009;20(4):486–91.  
Dwek RA. Glycobiology: Toward understanding the function of sugars. Chem Rev. 1996;96(2):683–
720.  
Dyballa N, Metzger S. Fast and sensitive colloidal coomassie G-250 staining for proteins in 
polyacrylamide gels. J Vis Exp. 2009;30(30):2–5.  
Erich S, Kuschel B, Schwarz T, Ewert J, Böhmer N, Niehaus F, et al. Novel high-performance 
metagenome β-galactosidases for lactose hydrolysis in the dairy industry. J Biotechnol. Elsevier 
B.V.; 2015;210:27–37.  
Estevez JM, Ciancia M, Cerezo AS. The system of sulfated galactans from the red seaweed 
Gymnogongrus torulosus (Phyllophoraceae, Rhodophyta): Location and structural analysis. 
Carbohydr Polym. 2008;73(4):594–605.  
Evans N, Hoyne P, Stone B. Characteristics and specificity of the interaction of a fluorochrome from 
aniline blue (sirofluor) with polysaccharides. Carbohydr Polym. 1984;4(3):215–30.  
Farinas E t, Butler T, Arnold FH. Directed enzyme evolution. Curr Opin Biotechnol. 2001;12:545–51.  
Feick K. European prebiotics market diversifies strongly across new application sectors in food and 
beverage industry. Frost & Sullivan. London; 2009 May 26;1–2.  
Feng HY, Drone J, Hoffmann L, Tran V, Tellier C, Rabiller C, et al. Converting a β-glycosidase into a 
β-transglycosidase by directed evolution. J Biol Chem. 2005;280(44):37088–97.  
Figueroa-González I, Quijano G, Ramírez G, Cruz-Guerrero A. Probiotics and prebiotics-perspectives 
and challenges. J Sci Food Agric. 2011;91(8):1341–8.  
Fowler A, Zabin I. Amino acid sequence of β-galactosidase. XI. Peptide ordering procedures and the 
complete sequence. J Biol Chem. 1978;253:5521–5.  
Fox RJ, Clay MD. Catalytic effectiveness, a measure of enzyme proficiency for industrial applications. 
Trends Biotechnol. 2009;27(3):137–40.  
Frenzel M, Zerge K, Clawin-Rädecker I, Lorenzen PC. Comparison of the galacto-oligosaccharide 
forming activity of different β-galactosidases. LWT - Food Sci Technol. 2015;60(2):1068–71.  
Stellenbosch University  https://scholar.sun.ac.za
69 
 
Fric P. Probiotics and prebiotics — renaissance of a therapeutic principle. Cent Eur J Med. 
2007;2(3):237–70.  
Gans J, Wolinsky M, Dunbar J. Computational improvements reveal great bacterial diversity and high 
metal toxicity in soil. Science (80- ). 2006;309:1387–90.  
Gänzle MG. Enzymatic synthesis of galacto-oligosaccharides and other lactose derivatives (hetero-
oligosaccharides) from lactose. Int Dairy J. Elsevier Ltd; 2012;22:116–22.  
Gänzle MG, Haase G, Jelen P. Lactose: Crystallization, hydrolysis and value-added derivatives. Int 
Dairy J. 2008;18(7):685–94.  
Gaur R, Pant H, Jain R, Khare SK. Galacto-oligosaccharide synthesis by immobilized Aspergillus 
oryzae β-galactosidase. Food Chem. 2006;97:426–30.  
Gebler JC, Aebersold R, Withers SG. Glu-537, not Glu-461, is the nucleophile in the active site of 
(lacZ) β-galactosidase from Escherichia coli. J Biol Chem. 1992;267(16):11126–30.  
Gibson GR, Probert HM, van Loo J, Rastall RA, Roberfroid MB. Dietary modulation of the human 
colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004;17:259–75.  
Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the 
concept of prebiotics. J Nutr. 1995;125(6):1401–12.  
Gloster TM, Roberts S, Ducros VM-A, Perugino G, Rossi M, Hoos R. Structural studies of the β-
glycosidase from Sulfolobus solfataricus in complex with covalently and noncovalently bound 
inhibitors. Biochemistry. 2004;43(20):6101–9.  
González Siso MI. The biotechnological utilization of cheese whey: A review. Bioresour Technol. 
1996;57(1):1–11.  
Gopal PK, Sullivan PA, Smart JB. Utilisation of galacto-oligosaccharides as selective substrates for 
growth by lactic acid bacteria including Bifidobacterium lactis DR10 and Lactobacillus 
rhamnosus DR20. Int Dairy J. 2001;11:19–25.  
Gosling A, Stevens GW, Barber AR, Kentish SE, Gras SL. Recent advances refining 
galactooligosaccharide production from lactose. Food Chem. Elsevier Ltd; 2010;121(2):307–18.  
Gosling A, Stevens GW, Barber AR, Kentish SE, Gras SL. Effect of the substrate concentration and 
water activity on the yield and rate of the transfer reaction of β-galactosidase from Bacillus 
circulans. J Agric Food Chem. 2011;59:3366–72.  
Greener A, Callahan M. XL1-RED: a highly efficient random mutagenesis strain. Strategies. 
1994;7:32–4.  
Greener A, Callahan M, Jerpseth B. An efficient random mutagenesis technique using an E. coli 
mutator strain. Mol Biotechnol. 1997;7:189–95.  
Grunert KG, Wills JM. A review of European research on consumer response to nutrition information 
on food labels. J Public Health (Bangkok). 2007;15(5):385–99.  
Guarner F, Malagelada J-R. Gut flora in health and disease. Lancet. 2003;360:512–9.  
Gupta R, Govil T, Capalash N, Sharma P. Characterization of a glycoside hydrolase family 1 β-
galactosidase from hot spring metagenome with transglycosylation activity. Appl Biochem 
Biotechnol. 2012;168(6):1681–93.  
Stellenbosch University  https://scholar.sun.ac.za
70 
 
Haider T, Husain Q. Concanavalin A layered calcium alginate-starch beads immobilized β-
galactosidase as a therapeutic agent for lactose intolerant patients. Int J Pharm. 2008;359:1–6.  
Hanahan D, Jessee J, Bloom FR. [4] Plasmid transformation of Escherichia coli and other bacteria. 
Methods Enzymol. 1991;204:63–114.  
Handelsman J. Metagenomics: application of genomics to uncultured microorganisms. Microbiol Mol 
Biol Rev. 2004;68(4):669–85.  
Hanning IB, Lingbeck JM, Ricke SC. Probiotics and heart health: Reduction of risk factors associated 
with cardiovascular disease and complications due to foodborne illnesses. First edit. Bioact. 
Foods Promot. Heal. Elsevier Inc.; 2010.  
Hansson T, Adlercreutz P. Enhanced transglucosylation/hydrolysis ratio of mutants of Pyrococcus 
furiosus β-glucosidase: Effects of donor concentration, water content, and temperature on 
activity and selectivity in hexanol. Biotechnol Bioeng. 2001a;75(6):656–65.  
Hansson T, Adlercreutz P. Optimization of galactooligosaccharide production from lactose using β-
glycosidases from hyperthermophiles. Food Biotechnol. 2001b;15(2):79–97.  
Hansson T, Kaper T, van Der Oost J, de Vos WM, Adlercreutz P. Improved oligosaccharide synthesis 
by protein engineering of β-glucosidase CelB from hyperthermophilic Pyrococcus furiosus. 
Biotechnol Bioeng. 2001;73(3):203–10.  
Harada M, Inohara M, Nakao M, Nakayama T, Kakudo A, Shibano Y, et al. Divalent metal ion 
requirements of a thermostable multimetal β-galactosidase from Saccharopolyspora rectivirgula. 
J Biol Chem. 1994;269(35):22021–6.  
Henne A, Schmitz RA, Bömeke M, Daniel R, Gottschalk G. Screening of environmental DNA libraries 
for the presence of genes conferring lipolytic activity on Escherichia coli. Appl Environ Microbiol. 
2000;66:3113–6.  
Henrissat B. A classification of glycosyl hydrolases based sequence on amino acid similarities. 
Biochem J. 1991;280:309–16.  
Henrissat B, Bairoch A. New families in the classification of glycosyl hydrolases based on amino acid 
sequence similarities. Biochem J. 1993;293:781–8.  
Henrissat B, Bairoch A. Updating the sequence-based classification of glycosyl hydrolases. Biochem 
J. 1996;316:695–6.  
Henrissat B, Davies G. Structural and sequence-based classification of glycoside hydrolases. Curr 
Opin Struct Biol. 1997;7(5):637–44.  
Hibbert EG, Baganz F, Hailes HC, Ward JM, Lye GJ, Woodley JM, et al. Directed evolution of 
biocatalytic processes. Biomol Eng. 2005;22:11–9.  
Hidaka M, Fushinobu S, Ohtsu N, Motoshima H, Matsuzawa H, Shoun H, et al. Trimeric crystal 
structure of the glycoside hydrolase family 42 β-galactosidase from Thermus thermophilus A4 
and the structure of its complex with galactose. J Mol Biol. 2002;322(1):79–91.  
Hinz SWA, Doeswijk-Voragen CHL, Schipperus R, Van Den Broek LA., Vincken JP, Voragen AGJ. 
Increasing the transglycosylation activity of alpha-galactosidase from Bifidobacterium 
adolescentis DSM 20083 by site-directed mutagenesis. Biotechnol Bioeng. 2005;93(1):122–31.  
Stellenbosch University  https://scholar.sun.ac.za
71 
 
Horwitz JP, Chua J, Curby RJ, Tomson AJ, Da Rooge MA, Fisher BE, et al. Substrates for 
cytochemical demonstration of enzyme activity. I. Some substituted 3-Indolyl-β-D-
glycopyranosides. J Med Chem. 1964;7(4):574–5.  
Hoyoux A, Jennes I, Dubois P, Genicot S, Dubail F, François JM, et al. Cold-adapted β-galactosidase 
from the Antarctic psychrophile Pseudoalteromonas haloplanktis. Appl Environ Microbiol. 
2001;67(4):1529–35.  
Hsu CA, Lee SL, Chou C. C. Enzymatic production of galactooligosaccharides by β-galactosidase 
from Bifidobacterium longum BCRC 15708. J Agric Food Chem. 2007;55(6):2225–30.  
Huber RE, Hakda S, Cheng C, Cupples CG, Edwards RA. Trp-999 of β-galactosidase (Escherichia 
coli) is a key residue for binding, catalysis, and synthesis of allolactose, the natural Lac operon 
inducer. Biochemistry. 2003;42(6):1796–803.  
Huber RE, Kurz G, Wallenfels K. A quantitation of the factors which affect the hydrolase and 
transgalactosylase activities of β-galactosidase (E. coli) on lactose. Biochemistry. 
1976;15(9):1994–2001.  
Huber RE, Parfett C, Woulfe-Flanagan H, Thompson DJ. Interaction of divalent cations with β-
galactosidase (Escherichia coli). Biochemistry. 1979;18(19):4090–5.  
Husain Q. β-galactosidases and their potential applications: a review. Crit Rev Biotechnol. 
2010;30(1):41–62.  
Iqbal HA, Feng Z, Brady SF. Biocatalysts and small molecule products from metagenomic studies. 
Curr Opin Chem Biol. 2012;16(1-2):109–16.  
Jäckel C, Kast P, Hilvert D. Protein design by directed evolution. Annu Rev Biophys. 2008;37:153–73.  
Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol. 
1961;3:318–56.  
Jacobson R, Zhang X, DuBose R, Matthews B. Three-Dimensional structure of β-galactosidase from 
E. coli. Lett to Nat. 1994;369:761–6.  
Jørgensen F, Hansen OC, Stougaard P. High-efficiency synthesis of oligosaccharides with a 
truncated β-galactosidase from Bifidobacterium bifidum. Appl Microbiol Biotechnol. 2001;57(5-
6):647–52.  
Juajun O, Nguyen TH, Maischberger T, Iqbal S, Haltrich D, Yamabhai M. Cloning, purification, and 
characterization of β-galactosidase from Bacillus licheniformis DSM 13. Appl Microbiol 
Biotechnol. 2011;89(3):645–54.  
Juers D, Wigley R, Zhang X, Huber R, Tronrud D, Matthews B. High resolution refinement of β-
galactosidase in a new crystal form reveals multiple metal binding sites and provides a structural 
basis for alpha complementation. Protein Sci. 2000;9:1685–99.  
Juers DH, Heightman TD, Vasella A, McCarter JD, Mackenzie L, Withers SG, et al. A structural view 
of the action of Escherichia coli (lacZ) β-galactosidase. Biochemistry. 2001;40(49):14781–94.  
Juers DH, Matthews BW, Huber RE. LacZ β-galactosidase: Structure and function of an enzyme of 
historical and molecular biological importance. Protein Sci. 2012;21(12):1792–807.  
Jung HK, Hong JH, Park SC, Park BK, Nam DH, Kim SD. Production and physicochemical 
characterization of β-glucan produced by Paenibacillus polymyxa JB115. Biotechnol Bioprocess 
Eng. 2007;12:713–9.  
Stellenbosch University  https://scholar.sun.ac.za
72 
 
Kalnins A, Otto K, Ruther U, Muller-Hill B. Sequence of the lacZ gene of Escherichia coli. EMBO J. 
1983;2:593–7.  
Kim CS, Ji E-S, Oh D-K. Expression and characterization of Kluyveromyces lactis β-galactosidase in 
Escherichia coli. Biotechnol Lett. 2003;25(20):1769–74.  
Kitazawa K, Tryfona T, Yoshimi Y, Hayashi Y, Kawauchi S, Antonov L, et al. β-Galactosyl Yariv 
reagent binds to the β-1,3-galactan of arabinogalactan proteins. Plant Physiol. 
2013;161(3):1117–26.  
Kittl R, Withers SG. New approaches to enzymatic glycoside synthesis through directed evolution. 
Carbohydr Res. Elsevier Ltd; 2010;345(10):1272–9.  
Klewicki R. The stability of gal-polyols and oligosaccharides during pasteurization at a low pH. LWT. 
2007;40(7):1259–65.  
Kries H, Blomberg R, Hilvert D. De novo enzymes by computational design. Curr Opin Chem Biol. 
2013;17(2):221–8.  
Kunz C, Rudloff S. Health promoting aspects of milk oligosaccharides. Int Dairy J. 2006;16(11):1341–
6.  
Labrou NE. Directed enzyme evolution: Bridging the gap between natural enzymes and commercial 
applications. Biomol Eng. 2005;22:7–9.  
Lamsal BP. Production, health aspects and potential food uses of dairy prebiotic 
galactooligosaccharides. J Sci Food Agric. 2012;92(10):2020–8.  
Di Lauro B, Strazzulli A, Perugino G, La Cara F, Bedini E, Michela MM, et al. Isolation and 
characterization of a new family 42 β-galactosidase from the thermoacidophilic bacterium 
Alicyclobacillus acidocaldarius: Identification of the active site residues. Biochim Biophys Acta. 
2008;1784:292–301.  
Lee JH, Kim YS, Yeom SJ, Oh DK. Characterization of a glycoside hydrolase family 42 β-
galactosidase from Deinococcus geothermalis. Biotechnol Lett. 2011;33(3):577–83.  
Li SC, Han JW, Chen KC, Chen CS. Purification and characterization of isoforms of β-galactosidases 
in mung bean seedlings. Phytochemistry. 2001;57(3):349–59.  
Li X, Zhang Z, Song J. Computational protein design approaches with significant biological outcomes: 
progress and challenges. Comput Struct Biotechnol J. 2012;2(3):1–12.  
Li Y, Wang H, Lu L, Li Z, Xu X, Xiao M. Purification and characterization of a novel β-galactosidase 
with transglycosylation activity from Bacillus megaterium 2-37-4-1. Appl Biochem Biotechnol. 
2009;158(1):192–9.  
Lo S, Dugdale ML, Jeerh N, Ku T, Roth NJ, Huber RE. Studies of Glu-416 variants of β-galactosidase 
(E. coli) Show that the active site Mg2+ is not important for structure and indicate that the main 
role of Mg2+ is to mediate optimization of active site chemistry. Protein J. 2010;29(1):26–31.  
Lombard V, Golaconda Ramulu H, Drula E, Coutinho P, Henrissat B. The Carbohydrate-active 
enzymes database (CAZy) in 2013. Nucleic Acids Res. 2014;42:D490–5.  
Lu X, Hirata H, Yamaji Y, Ugaki M, Namba S. Random mutagenesis in a plant viral genome using a 
DNA repair-deficient mutator Escherichia coli strain. J Virol Methods. 2001;94(1-2):37–43.  
Stellenbosch University  https://scholar.sun.ac.za
73 
 
Lutz S, Patrick WM. Novel methods for directed evolution of enzymes: Quality, not quantity. Curr Opin 
Biotechnol. 2004;15(4):291–7.  
Ly HD, Withers SG. Mutagenesis of glycosidases. Annu Rev Biochem. 1999;68:487–522.  
Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-
oligosaccharides and other prebiotics. J Appl Microbiol. 2008;104(2):305–44.  
Mackenzie LF, Wang Q, Warren RAJ, Withers SG. Glycosynthases: Mutant glycosidases for 
oligosaccharide synthesis. J Am Chem Soc. 1998;120(16):5583–4.  
Mahoney RR. Lactose: Enzymatic modification. In: Fox P., editor. Adv Dairy Chem Vol 3 Lact water, 
salts Vitam. 2nd ed. London: Chapman & Hall; 1997. p. 78–126.  
Mahoney RR. Galactosyl-oligosaccharide formation during lactose hydrolysis: A review. Food Chem. 
1998;63(2):147–54.  
Maksimainen M, Paavilainen S, Hakulinen N, Rouvinen J. Structural analysis, enzymatic 
characterization, and catalytic mechanisms of β-galactosidase from Bacillus circulans sp. 
alkalophilus. FEBS J. 2012;279:1788–98.  
Maksimainen M, Rouvinen J. Crystal structures of Trichoderma reesei β-galactosidase reveal 
conformational changes in the active site. J Struct Biol. 2011;174:156–63.  
Marín-Manzano MC, Abecia L, Hernández-Hernández O, Sanz ML, Montilla A, Olano A, et al. 
Galacto-oligosaccharides derived from lactulose exert a selective stimulation on the growth of 
Bifidobacterium animalis in the large intestine of growing rats. J Agric Food Chem. 
2013;61(31):7560–7.  
Martínez-Villaluenga C, Cardelle-Cobas A, Corzo N, Olano A. Study of galactooligosaccharide 
composition in commercial fermented milks. J Food Compos Anal. 2008a;21(7):540–4.  
Martínez-Villaluenga C, Cardelle-Cobas A, Corzo N, Olano A, Villamiel M. Optimization of conditions 
for galactooligosaccharide synthesis during lactose hydrolysis by β-galactosidase from 
Kluyveromyces lactis (Lactozym 3000 L HP G). Food Chem. 2008b;107(1):258–64.  
Martínez-Villaluenga C, Cardelle-Cobas A, Olano A, Corzo N, Villamiel M, Jimeno ML. Enzymatic 
synthesis and identification of two trisaccharides produced from lactulose by 
transgalactosylation. J Agric Food Chem. 2008c;56(2):557–63.  
Mattila-Sandholm T, Myllärinen P, Crittenden R, Mogensen G, Fondén R, Saarela M. Technological 
challenges for future probiotic foods. Int Dairy J. 2002;12(2-3):173–82.  
Maugard T, Gaunt D, Legoy MD, Besson T. Microwave-assisted synthesis of galacto-
oligosaccharides from lactose with immobilized β-galactosidase from Kluyveromyces lactis. 
Biotechnol Lett. 2003;25:623–9.  
McWilliam H, Li W, Uludag M, Squizzato S, Park Y, Buso N, et al. Analysis tool web services from the 
EMBL-EBI. Nucleic Acids Res. 2013;41:597–600.  
Muraki M. The Importance of CH/π interactions to the function of carbohydrate binding proteins. 
Protein Pept Lett. 2002;9(3):195–209.  
Mussatto SI, Mancilha IM. Non-digestible oligosaccharides: A review. Carbohydr Polym. 
2007;68(3):587–97.  
Stellenbosch University  https://scholar.sun.ac.za
74 
 
Nakanishi I, Kimura K, Suzuki T, Ishikawa M, Banno I, Sakane T, et al. Demonstration of curdlan-type 
polysaccharide and some other β-1, 3-glucan in microorganisms with aniline blue. J Gen Appl 
Microbiol. 1976;22:1–11.  
Nam Shin J, Maradufu A, Marion J, Perlin A. Specificity of α- and β-D-galactosidase towards analogs 
of D-galactopyranosides modified at C-4 or C-5. Carbohydr Res. 1980;84:328–35.  
Neylon C. Chemical and biochemical strategies for the randomization of protein encoding DNA 
sequences: Library construction methods for directed evolution. Nucleic Acids Res. 
2004;32(4):1448–59.  
Nie C, Liu B, Zhang Y, Zhao G, Fan X, Ning X, et al. Production and secretion of Lactobacillus 
crispatus β-galactosidase in Pichia pastoris. Protein Expr Purif. Elsevier Inc.; 2013;92(1):88–93.  
Ohr LM. Health benefits of probiotics and prebiotics. Food Technol. 2010;64(3):59–64.  
Ohto U, Usui K, Ochi T, Yuki K, Satow Y, Shimizu T. Crystal structure of human β-galactosidase: 
Structural basis of G M1 gangliosidosis and morquio B diseases. J Biol Chem. 
2012;287(3):1801–12.  
Ohtsu N, Motoshiuma H, Goto K, Tsukasaki F, Matsuzawa H. Thermostable β-galactosidase from an 
extreme thermophile, Thermus sp. A4: Enzyme purification and characterization, and gene 
cloning and sequencing. Biosci Biotechnol Biochem. 1998;62(8):1539–45.  
Oliveira C, Guimarães PMR, Domingues L. Recombinant microbial systems for improved β-
galactosidase production and biotechnological applications. Biotechnol Adv. Elsevier B.V.; 
2011;29(6):600–9.  
Oshima A, Tsuji A, Nagao Y, Sakuraba H, Suzuki Y. Cloning, sequencing and expression of cDNA for 
human β-galactosidase. Biochem Biophys Res Commun. 1988;157(1):238–44.  
Otieno DO. Synthesis of β-galactooligosaccharides from lactose using microbial β-galactosidases. 
Compr Rev Food Sci Food Saf. 2010;9(5):471–82.  
Otten LG, Quax WJ. Directed evolution: Selecting today’s biocatalysts. Biomol Eng. 2005;22(1-3):1–9.  
Palai T, Mitra S, Bhattacharya PK. Kinetics and design relation for enzymatic conversion of lactose 
into galacto-oligosaccharides using commercial grade β-galactosidase. J Biosci Bioeng. Elsevier 
Ltd; 2012;114(4):418–23.  
Panesar P., Panesar R, Singh RS, Kennedy JF, Kumar H. Microbial production, immobilization and 
applications of β-D-galactosidase. J Chem Technol Biotechnol. 2006;81(4):530–43.  
Panke S, Held M, Wubbolts M. Trends and innovations in industrial biocatalysis for the production of 
fine chemicals. Curr Opin Biotechnol. 2004;15(4):272–9.  
Park AR, Oh DK. Effects of galactose and glucose on the hydrolysis reaction of a thermostable β-
galactosidase from Caldicellulosiruptor saccharolyticus. Appl Microbiol Biotechnol. 
2010a;85(5):1427–35.  
Park A-R, Oh D-K. Galacto-oligosaccharide production using microbial β-galactosidase: current state 
and perspectives. Appl Microbiol Biotechnol. 2010b;85(5):1279–86.  
Pawlak-Szukalska A, Wanarska M, Popinigis AT, Kur J. A novel cold-active β-D-galactosidase with 
transglycosylation activity from the Antarctic Arthrobacter sp. 32cB – Gene cloning, purification 
and characterization. Process Biochem. Elsevier Ltd; 2014;49(12):2122–33.  
Stellenbosch University  https://scholar.sun.ac.za
75 
 
Pazur J. The enzymatic conversion of lactose into galactosyl oligosaccharides. Science (80- ). 
1953;117(3040):355–6.  
Pereira-Rodríguez Á, Fernández-Leiro R, González-Siso MI, Cerdán ME, Becerra M, Sanz-Aparicio J. 
Structural basis of specificity in tetrameric Kluyveromyces lactis β-galactosidase. J Struct Biol. 
2012;177(2):392–401.  
Perugino G, Cobucci-Ponzano B, Rossi M, Moracci M. Recent advances in the oligosaccharide 
synthesis promoted by catalytically engineered glycosidases. Adv Synth Catal. 2005;347(7-
8):941–50.  
Perugino G, Trincone A, Rossi M, Moracci M. Oligosaccharide synthesis by glycosynthases. Trends 
Biotechnol. 2004;22(1):31–7.  
Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from 
transmembrane regions. Nat Methods. 2011;8:785–6.  
Placier G, Watzlawick H, Rabiller C, Mattes R. Evolved β-galactosidases from Geobacillus 
stearothermophilus with improved transgalactosylation yield for galacto-oligosaccharide 
production. Appl Environ Microbiol. 2009;75(19):6312–21.  
Pollard DJ, Woodley JM. Biocatalysis for pharmaceutical intermediates: The future is now. Trends 
Biotechnol. 2007;25:66–73.  
Prazeres AR, Carvalho F, Rivas J. Cheese whey management: A review. J Environ Manage. Elsevier 
Ltd; 2012;110:48–68.  
Quintero M, Maldonado M, Perez-Munoz M, Jimenez R, Fangman T, Rupnow J, et al. Adherence 
inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides. Curr 
Microbiol. 2011;62:1448–54.  
Rabiu BA, Jay AJ, Gibson GR, Rastall RA. Synthesis and fermentation properties of novel 
galactooligosaccharides by β-galactosidases from Bifidobacterium species. Appl Environ 
Microbiol. 2001;67(6):2526–30.  
Rasila TS, Pajunen MI, Savilahti H. Critical evaluation of random mutagenesis by error-prone 
polymerase chain reaction protocols, Escherichia coli mutator strain, and hydroxylamine 
treatment. Anal Biochem. Elsevier Inc.; 2009;388(1):71–80.  
Richmond ML, Gray JI, Stine CM. β-Galactosidase: Review of recent research related to 
technological application. J Dairy Sci. 1981;64:1759–71.  
Rivero-Urgell M, Santamaria-Orleans A. Oligosaccharides: Application in infant food. Early Hum Dev. 
2001;65:43–52.  
Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, et al. Prebiotic effects: 
metabolic and health benefits. Br J Nutr. 2010;S1–63.  
Roberfroid M, Slavin J. Non-digestible oligosaccharides. Crit Rev Food Sci Nutr. 2000;40(6):461–80.  
Roberts HR, Pettinati JD. Concentration effects in the enzymatic conversion of lactose to 
oligosaccharides. J Agric Food Chem. 1957;5(2):130–4.  
Rodriguez-Colinas B, Fernandez-Arrojo L, Ballesteros AO, Plou FJ. Galactooligosaccharides 
formation during enzymatic hydrolysis of lactose: Towards a prebiotic-enriched milk. Food 
Chem. Elsevier Ltd; 2014;145:388–94.  
Stellenbosch University  https://scholar.sun.ac.za
76 
 
Rojas a. L, Nagem R a P, Neustroev KN, Arand M, Adamska M, Eneyskaya E V., et al. Crystal 
structures of β-galactosidase from Penicillium sp. and its complex with galactose. J Mol Biol. 
2004;343(5):1281–92.  
Rondon MR, Al E. Cloning the soil metagenome: a strategy for accessing the genetic and functional 
diversity of uncultured microorganisms. Appl Environ Microbiol. 2000;66(6):2541–7.  
De Roos A. Industrial enzymes: enzymes in dairy applications. In: Aehle W, editor. Enzym Ind. 2nd 
ed. Weinheim: Wiley-VCH; 2004. p. 144.  
Ruas-Madiedo P, de los Reyes-Gavilán CG. Invited review: methods for the screening, isolation, and 
characterization of exopolysaccharides produced by lactic acid bacteria. J Dairy Sci. 
2005;88(3):843–56.  
Saier MH, Mansour NM. Probiotics and prebiotics in human health. J Mol Microbiol Biotechnol. 
2005;10(1):22–5.  
Sako T, Matsumoto K, Tanaka R. Recent progress on research and applications of non-digestible 
galacto-oligosaccharides. Int Dairy J. 1999;9(1):69–80.  
Sambrook J, Russell D. Molecular Cloning: A Laboratory Manual. Third. Cold Spring Harbour, New 
York: Cold Spring Harbour Labratory Press; 2000.  
Sangwan V, Tomar SK, Singh RRB, Singh a. K, Ali B. Galactooligosaccharides: Novel components of 
designer foods. J Food Sci. 2011;76(4):103–11.  
Sanz Y, Santacruz A. Probiotics and prebiotics in metabolic disorders and obesity. First edit. Bioact. 
Foods Promot. Heal. Elsevier Inc.; 2010.  
Schmeisser C, Sto C, Raasch C, Wingender J, Timmis KN, Wenderoth DF, et al. Metagenome survey 
of biofilms in drinking-water networks. Appl Environ Microbiol. 2003;69:7298–309.  
Schmidt-Dannert C, Arnold FH. Directed evolution of industrial enzymes. Trends Biotechnol. 
1999;17:135–6.  
Scholz-Ahrens KE, Van Looo J, Schrezenmeir J. Effect of oligosaccharides on gut flora metabolism in 
rat associated with a human faecal microflora. J Appl Bacteriol. 1998;74:667–74.  
Scholz-Ahrens KE, Schaafsma G, Van den Heuvel EG, Schrezenmeir J. Effects of prebiotics on 
mineral metabolism. Am J Clin Nutr. 2001;73:459S – 464S.  
Searle LEJ, Cooley WA, Jones G, Nunez A, Crudgington B, Weyer U, et al. Purified 
galactooligosaccharide, derived from a mixture produced by the enzymic activity of 
Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium adhesion and 
invasion in vitro and in vivo. J Med Microbiol. 2010;59:1428–39.  
Sears P, Wong C-H. Toward automated synthesis of oligosaccharides and glycoproteins. Science 
(80- ). 2001;291:2344–50.  
Shifrin S, Hunn G. Effects of alcohols on the enzymatic activity and subunit association of β-
galactosidase. Arch Biochem Biophys. 1969;130:530–5.  
Shin H-J, Yang J-W. Galacto-oligosaccharide production by β-galactosidase in hydrophobic organic 
media. Biotechnol Lett. 1994;16(11):1157–62.  
Stellenbosch University  https://scholar.sun.ac.za
77 
 
Shukla TP. β-galactosidase technology: a solution to the lactose problem. Crit Rev Food Technol. 
1975;5(3):325–56.  
Shumway M V., Sheridan PP. Site-directed mutagenesis of a family 42 β-galactosidase from an 
antarctic bacterium. Int J Biochem Mol Biol. 2012;3(2):209–18.  
Simon C, Daniel R. Achievements and new knowledge unraveled by metagenomic approaches. Appl 
Microbiol Biotechnol. 2009;85(2):265–76.  
Sinclair HR, De Slegte J, Gibson GR, Rastall RA. Galactooligosaccharides (GOS) inhibit Vibrio 
cholerae toxin binding to its GM1 receptor. J Agric Food Chem. 2009;57(8):3113–9.  
Skálová T, Dohnálek J, Spiwok V, Lipovová P, Vondrácková E, Petroková H. Cold-active β-
galactosidase from Arthrobacter sp. C2-2 forms compact 660 kDa hexamers: Crystal structure at 
1.9 Å resolution. J Mol Biol. 2005;353(2):282–94.  
Smith DL, Gross KC. A family of at least seven β-galactosidase genes is expressed during tomato 
fruit development. Plant Physiol. 2000;123(3):1173–83.  
Socha RD, Tokuriki N. Modulating protein stability - Directed evolution strategies for improved protein 
function. FEBS J. 2013;280(22):5582–95.  
Srivastava A, Mishra S, Chand S. Transgalactosylation of lactose for synthesis of galacto-
oligosaccharides using Kluyveromyces marxianus NCIM 3551. N Biotechnol. Elsevier B.V.; 
2015;32(4):412–8.  
Steele HL, Jaeger KE, Daniel R, Streit WR. Advances in recovery of novel biocatalysts from 
metagenomes. J Mol Microbiol Biotechnol. 2008;16(1-2):25–37.  
Stick R, Williams S. Classics in carbohydrate chemistry and glycobiology. Carbohydrates Essent Mol 
Life. Elsevier; 2008. p. 415–43.  
Streit WR, Daniel R, Jaeger KE. Prospecting for biocatalysts and drugs in the genomes of non-
cultured microorganisms. Curr Opin Biotechnol. 2004;15(4):285–90.  
Studier FW. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif. 
2005;41:207–34.  
Sutendra G, Wong S, Fraser ME, Huber RE. β-Galactosidase (Escherichia coli) has a second 
catalytically important Mg2+ site. Biochem Biophys Res Commun. 2007;352(2):566–70.  
Terao Y, Miyamoto K, Ohta H. Improvement of the activity of arylmalonate decarboxylase by random 
mutagenesis. Appl Microbiol Biotechnol. 2006;73(3):647–53.  
Teze D, Hendrickx J, Czjzek M, Ropartz D, Sanejouand YH, Tran V, et al. Semi-rational approach for 
converting a GH1 β-glycosidase into a β-transglycosidase. Protein Eng Des Sel. 2014;27(1):13–
9.  
Theriot CM, Du X, Tove SR, Grunden AM. Improving the catalytic activity of hyperthermophilic 
Pyrococcus prolidases for detoxification of organophosphorus nerve agents over a broad range 
of temperatures. Appl Microbiol Biotechnol. 2010;87(5):1715–26.  
Torres DPM, Gonçalves MDPF, Teixeira JA, Rodrigues LR. Galactooligosaccharides: Production, 
properties, applications, and significance as prebiotics. Compr Rev Food Sci Food Saf. 
2010;9:438–54.  
Stellenbosch University  https://scholar.sun.ac.za
78 
 
Tran V, Hoffmann L, Rabiller C, Tellier C, Dion M. Rational design of a GH1 β-glycosidase to prevent 
self-condensation during the transglycosylation reaction. Protein Eng Des Sel. 2010;23(1):43–9.  
Triplett BA, Timpa JD. β-Glucosyl and α-galactosyl Yariv reagents bind to cellulose and other glucans. 
J Agric Food Chem. 1997;45:4650–4.  
Turner NJ. Directed evolution drives the next generation of biocatalysts. Nat Chem Biol. 
2009;5(8):567–73.  
Tzortzis G, Vulevic J. Galacto-oligosaccharides. In: Charalampopoulos D, Rastall R, editors. 
Prebiotics Probiotics Sci Technol. Springer; 2009. p. 207–43.  
Uchiyama T, Miyazaki K. Functional metagenomics for enzyme discovery: challenges to efficient 
screening. Curr Opin Biotechnol. 2009;20(6):616–22.  
Vedamuthu ER, Neville JM. Involvement of a plasmid in production of ropiness (mucoidness) in milk 
cultures by Streptococcus cremoris MS. Appl Environ Microbiol. 1986;51(4):677–82.  
Vincent V, Aghajari N, Pollet N, Boisson A, Boudebbouze S, Haser R, et al. The acid tolerant and 
cold-active β-galactosidase from Lactococcus lactis strain is an attractive biocatalyst for lactose 
hydrolysis. Antonie van Leeuwenhoek, Int J Gen Mol Microbiol. 2013;103(4):701–12.  
Voget S, Leggewie C, Uesbeck A, Raasch C, Jaeger KE, Streit WR. Prospecting for novel 
biocatalysts in a soil metagenome. Appl Environ Microbiol. 2003;69:6235–42.  
Voragen a. GJ. Technological aspects of functional food-related carbohydrates. Trends Food Sci 
Technol. 1998;9(8-9):328–35.  
De Vrese M, Offick B. Probiotics and prebiotics: effects on diarrhea. Bioact. Foods Promot. Heal. 
Elsevier Inc.; 2010.  
Wahler D, Reymond JL. High-throughput screening for biocatalysts. Curr Opin Biotechnol. 
2001;12(6):535–44.  
Wallenfels K. Enzymatische synthese von oligosacchariden aus disacchariden. Naturwissenschaften. 
1951;38(13):306.  
Wang GX, Gao Y, Hu B, Lu XL, Liu XY, Jiao BH. A novel cold-adapted β-galactosidase isolated from 
Halomonas sp. S62: Gene cloning, purification and enzymatic characterization. World J 
Microbiol Biotechnol. 2013;29(8):1473–80.  
Wang K, Li G, Yu SQ, Zhang CT, Liu YH. A novel metagenome-derived β-galactosidase: Gene 
cloning, overexpression, purification and characterization. Appl Microbiol Biotechnol. 
2010;88(1):155–65.  
Wang K, Lu Y, Liang WQ, Wang S Di, Jiang Y, Huang R, et al. Enzymatic synthesis of galacto-
oligosaccharides in an organic-aqueous biphasic system by a novel β-galactosidase from a 
metagenomic library. J Agric Food Chem. 2012;60(15):3940–6.  
Wang S Di, Guo GS, Li L, Cao LC, Tong L, Ren GH, et al. Identification and characterization of an 
unusual glycosyltransferase-like enzyme with β-galactosidase activity from a soil metagenomic 
library. Enzyme Microb Technol. 2014;57:26–35.  
Williamson JC, Taylor MD, Torrens RS, Vojvodic-Vukovic M. Reducing nitrogen leaching from dairy 
farm effluent-irrigated pasture using dicyandiamide: A lysimeter study. Agric Ecosyst Environ. 
1998;69:81–8.  
Stellenbosch University  https://scholar.sun.ac.za
79 
 
Wong TS, Roccatano D, Zacharias M, Schwaneberg U. A statistical analysis of random mutagenesis 
methods used for directed protein evolution. J Mol Biol. 2006;355(4):858–71.  
Wood PJ, Fulcher RG. Specific interaction of aniline blue with (1 → 3)-β-D-glucan. Carbohydr Polym. 
1984;4(1):49–72.  
Wu Y, Yuan S, Chen S, Wu D, Chen J, Wu J. Enhancing the production of galacto-oligosaccharides 
by mutagenesis of Sulfolobus solfataricus β-galactosidase. Food Chem. 2013;138(2-3):1588–
95.  
Xu J. Microbial ecology in the age of genomics and metagenomics: Concepts, tools, and recent 
advances. Mol Ecol. 2006;15(7):1713–31.  
Yang ST, Silva EM. Novel products and new technologies for use of a familiar carbohydrate, milk 
lactose. J Dairy Sci. Elsevier; 1995;78(11):2541–62.  
Yu L, O’Sullivan DJ. Production of galactooligosaccharides using a hyperthermophilic β-galactosidase 
in permeabilized whole cells of Lactococcus lactis. J Dairy Sci. 2014;97(2):694–703.  
Zhang X, Li H, Li C-J, Ma T, Li G, Liu Y-H. Metagenomic approach for the isolation of a thermostable 
β-galactosidase with high tolerance of galactose and glucose from soil samples of Turpan Basin. 
BMC Microbiol. 2013;13:237.  
Zinin AI, Eneyskaya E V, Shabalin KA, Kulminskaya AA, Shishlyannikov SM, Neustroev KN. 1-O-
Acetyl-β-D-galactopyranose: a novel substrate for the transglycosylation reaction catalyzed by 
the β-galactosidase from Penicillium sp. Carbohydr Res. 2002;337:635–42.  
 
 
Stellenbosch University  https://scholar.sun.ac.za
